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ABSTRACT
A STUDY OF BIOCHEMICAL MECHANISMS 
INVOLVED IN THE NEUROMUSCULAR BLOCKING 
ACTIVITIES OF SAXITOXIN AND TETRODOTOXIN
by
ELWOOD W. HOPKINS, III
The swelling properties and adenosine triphosphatase activities 
of isolated rat liver mitochondria were altered "by saxitoxin (SIX) and 
tetrodotoxin (TTX). Toxin-stimulation of mitochondrial latent ATPase 
activity is interpreted as being indicative of degradative effects of 
the toxins on mitochondrial membrane structure. These effects are con­
sistent with the reports of STX-induced kidney tubule mitochondria 
pathology and TTX-induced hypoglycemia. The toxins resemble other 
guanidine compounds in these respects. The actions of the toxins on 
mitochondria, however, are believed to be independent of the neuro­
muscular blocking properties of these compounds, and do not provide a 
satisfactory explanation for the lethal effects of STX and TTX.
Preliminary investigations of the effects of STX on shellfish 
physiology indicate that the neuromuscular system of Mytilus edulls is 
insensitive to this toxin. The heart of Mya arenarla. on the other hand, 
is readily blocked by STX. The implications of these findings are 
briefly discussed.
The toxins were also shown to be effective in inhibiting acetyl­
cholinesterase activity. The implications of these findings in reference 
to the conduction blocking actions of the toxins is discussed.
xi
Hat brain microsomal (Na^-K*)-activated ATPase activity is not 
inhibited by STX or TTX. Furthermore, the inhibitory actions of 
ouabain on this ATPase were not affected by the toxins. A ouabain- 
insensitive, rat brain microsomal ATPase was found to be sensitive to 
STX, although not to TTX. While the identity of this enzyme is uncertain, 
it seems clear that (Na^K*)-activated ATPase activity is not involved 
in the conduction blocking mechanism of STX and TTX.
Proteins similar to muscle actomyosin were isolated from crayfish 
ventral nerve cords and rat, rabbit, lamb, and bovine brains. These 
proteins were characterized by their solubility, chromatographic, ATPase, 
and superprecipitation properties. In addition, the ATPase activities of 
these proteins responded to differences in pH and divalent cations much 
the way actomyosin ATPase activity does. Like muscle actomyosin, the 
ATPase activity of the brain proteins was also inhibited by p-chloro- 
mercuribenzoate (PCiMB) and stimulated by 2-aminoetbylisothiouronium (AST). 
Brain actomyosin could be dissociated by ATP and the "actin* and "myosin* 
portions separated by gel filtration. The ATPase activity of brain 
myosin was quite low, however, and it is believed that adenosine nucleo­
tides, tightly bound to brain myosin, are responsible for some degree of 
this inactivation. The possibility that specific activating substances, 
perhaps phospholipid, are required for expression of the ATPase activity 
is also favored as an explanation for the low enzymatic activity. A 
pyrophosphate muscle myosin extraction procedure was found to yield a 
protein from brain tissue that chromatographically resembled myosin.
The ATPase activity of this preparation also decreased with increasing 
stages of purification, again favoring the explanation that an activating
xii
substance is being lost as the preparation progresses. An essential 
role for contractile proteins in the molecular mechanism of nerve 
membrane excitation is discussed and it is suggested that the neuronal 
actomyosin-like proteins studied in the course of this research are 
components of nerve membranes, functioning as subunits, in complexes 
with phospholipids, capable of undergoing conformational transitions 
in response to nerve stimulation. Membrane subunit conformational 
transitions presumably could control the ionic conductance changes 
associated with action potential generation and impulse conduction.
The ATPase and superprecipitation activities of muscle as well 
as neuronal contractile proteins were inhibited by STX and TTX, in a 
noncompetitive fashion. Toxin-inhibition of contractile protein 
activities was characterized by the presence of a lag phase in the 
enzymatic activities. It is firmly believed that the actions of the 
toxins on contractile proteins present in electrically excitable cell 
membranes is the biochemical mechanism involved in the neuromuscular 




1. Statement of Purpose 
It was the designed purpose of this research venture to 
elucidate the biochemical mechanisms involved in the neuromuscular 
blocking activities of two pharmacologically similar marine 
biotoxins, saxitoxin (STX) and tetrodotoxin (TTX).
Secondarily, it was felt that elucidation of the mechanism 
of action of these toxins would make a significant contribution to 
our understanding of the molecular events occurring during 
electrical impulse generation and conduction in nerve and muscle 
cells.
The isolation, partial purification, and characterization 
of neuronal “contractile proteins" became an integral concern of 
this project. The thesis developed upon the implication of these 
proteins in membrane bioelectricity and the interactions of STX 
and TTX with the activities of such proteins. The demonstration 
of their occurrence in neuronal tissue, their possible identity 
with other contractile proteins, and investigation of their 
possible role in electrically excitable cell membranes seemed 
worthy of pursuit as a correlative study of molecular mechanisms 
implicit in neuromuscular activity.
2. Literature Review 
Saxitoxin and tetrodotoxin are the agents responsible for 
paralytic shellfish poisoning and puffer-fish poisoning,
respectively, and are among the most potent non-protein toxins 
known (for reviews see 1-11).
Paralytic shellfish poisoning (also called clam or 
mussel poisoning) has been traced back to Biblical history 
(Exodus 7« 20-21) and occurs endemically in several regions of
the world today I the California coast, the Bay of Fundy, the 
Gulf of Mexico, the North Atlantic coastal regions, and Cape 
Town, South Africa, to name a few. In nearly all instances of 
paralytic shellfish poisoning, dinoflagellates have been 
implicated as the initial sources of the toxic principles.
The name saxitoxin has been given to the toxin isolated from 
Giant Alaska Butter Clams, Saxldomus giganteus (12) and a 
similar, if not identical, compound has been isolated from 
toxic mussels and scallops (15-22), and from axenic cultures 
of the dinoflagellate, Gonyaulax catenella (1J, 16, 17, 19).
STX is also called paralytic shellfish poison (PSP), clam or 
mussel toxin, and Gonyaulax toxin.
Puffer-fish or fugu poisoning is prevalent in countries 
bordering the South China Sea, particularly Japan, and results 
from ingestion of fish belonging to the suborder Gymnodontes, 
the puffer-fish. The toxic principle elaborated by puffer-fish 
has been purified and its structure determined (25-26); it has 
become known as tetrodotoxin (TTX), spheroidin, fugu poison, 
and tarichatoxin (referable to the curious finding that a 
California newt, Taricha torosa contains a compound that is 
identical with TTX, ref. 24, 27, 28).
3Saxitoxin
Although several dinoflagellates have been implicated as 
toxin sources only one, Gonyaulax catenella. has been extensively 
investigated and shown to synthesize STX (1J» 16, 17, 19).
G. catenella might not be the only source of STX however, since 
chromatographically similar toxins have been isolated from 
cultures of a blue-green alga, Aphanlzomenon flosaquae (29) and 
from a Japanese crab (JO). In addition, the source of the toxin 
present in the Alaska Butter Clam has never been found (21).
Sommer and Meyer (J1) first demonstrated that California 
mussels became toxic by feeding in "blooms" of G^ catenella and 
that subsequent ingestion of these mussels by humans was 
responsible for paralytic shellfish poisoning. Ingestion of 
as little as 1.0 mg of STX may be fatal to humans (J2).
STX is about 160,000 times more potent than cocaine in 
blocking axonal conduction (5) and produces generalized 
conduction block in nerves and skeletal muscles by specifically 
inhibiting the early ionic conductance phase of action potentials, 
while not affecting the resting membrane potentials of these 
cells (35). Neuromuscular synaptic transmission is little 
affected by conduction-blocking concentrations of STX (19, 34-3®)* 
Isolated uterine and intestinal smooth muscles are not affected 
by STX (59).
The chemistry of STX has been studied by Schuett and 





It is a strongly basic, hydrophilic, cyclic guanidinium 
compound of molecular weight 572 and empirical formula .
While it structurally resembles caffeine and the barbiturates, 
its biological actions more closely resemble those of the local 
anesthetics, e.g. procaine. Seduction of a single double bond, 
resulting in the production of dihydro-SIX, renders the compound 
completely inactive (18).
With few exceptions, the effects of STX on biochemical 
systems are poorly understood and not well investigated.
Cleavage of sea urchin eggs is retarded by SIX (41) and it is 
felt that the “hatching enzyme* of Arbacia is directly acted upon 
by SIX (42).
Bolton et al.(54) concluded that the neuromuscular 
synaptic cholinesterase system was little affected by paralysing 
concentrations of the toxin. While the resting membrane potentials 
of lobster axons are unaffected by SIX (55)» Clapham and JSvans (45) 
found that SIX reduced 2% a  exchange in non-st imulated frog 
sartorius muscles, thus leaving open the possibility that SIX 
might have an effect on active cation transport.
5Wiberg and Stephenson (44,45) found that the toxicity of 
STX to mice could be reduced, for the intra-peritoneal route 
only, by the inclusion of sodium ions in the injection medium. 
The lethal effect of the toxin was enhanced by Ca44, Ba.**, St**, 
Mg44, Mn44, Co44, Ni44, Fe44, and Fe444. Other di-, tri-, and 
tetra-valent ions had no influence on the toxin's activity. 
Halstead (1) interpreted this as possibly meaning that an enzyme, 
such as choline acetylase, known to be stimulated by sodium ions 
and inhibited by calcium and magnesium ions, might be acted upon 
by STX.
Halstead (1) further notes that the toxin does not affect 
oxygen uptake by respiring diaphragms nor does it inhibit the 
mechanism involved in the conversion of AH’ to ATP by means of 
creatine phosphate. Toxicity is not lost following contact with 
blood plasma or urine; however, some reduction in toxicity occurs 
when the toxin is bathed in liver, kidney, or muscle homogenates. 
Without providing details, Halstead (1) also states that the 
action of APP on muscle contraction is unaffected by STX.
Cheymol and Bourillet (46) reported that SIX was not toxic 
to HeLa cell cultures.
Finally, Cohen et al.(47) demonstrated that STX altered 
the light scattering and birefringence changes occurring in nerve 
cell membranes during excitation. They suggested that the action 
of STX might involve some kind of cooperative or allosteric 
phenomenon with specific regions of the membrane.
6Tetrodotoxin
TTX, although slightly more potent than STX (2, 5, 11, 24), 
has biological actions qualitatively similar to STX (58). TTX, 
like STX, is a non-depolarizing, neuromuscular blocking agent which 
specifically inhibits the early ionic conductance phase of action 
potentials (19, 27, 55. 58* 48-52).
Smooth muscles (55) and cells dependent upon calcium as the 
conducting ion for action potential generation (54-61) are not 
affected by TTX. Calcium mobility associated with muscle activity 
is not inhibited by TTX (62, 65), which is in contrast with the 
effects of procaine.
Kao (64, 65) has compared the actions of STX and TTX, and 
has demonstrated that the puffer fish and the newt neuromuscular 
systems are highly resistant to the actions of TTX; however, they 
are sensitive to the blocking action of STX.
Irihile the toxins are pharmacologically quite similar,
chemically they are distinct. The structure of TTX has been
elucidated by several independent laboratories (25-26)1 C H N 0




7like STX, TTX is a cyclic guanidlnium compound of low 
molecular weight (J19) and is hydrophilic. The presence of 
several hydroxyl groups distinguishes it from STX. The amino- 
perhydroquinazoline structure of TTX is unique in organic 
chemistry and further distinguishes TTX from SIX.
Extensive studies of several TTX derivatives (66-68) and 
synthetic guanidine esters related to TTX (69, 70) have revealed 
the essentiality of the entire TTX structure in the maintenance 
of its biological activity. Although a few of the TTX derivatives 
and the synthetic guanidine esters possessed activities that 
qualitatively resembled those of TTX, none of the compounds 
studied ever approached the potency of TTX.
Camougis et al. (71) found the cationic form of TTX to be 
more active than the zwitterion and suggested the toxin might be 
interacting with receptors on the nerve membrane through either 
hydrogen bonding, electrostatic attraction, or inter-molecular 
hsmilactal formation. In slight disagreement, Ogura and Mori (68) 
found that although the cationic form of the toxin was more active 
in blocking desheathed nerve preparations, the zwitterionic form 
was more effective in blocking nerves that bad not been desheathed. 
They attributed this observation to the probability that the 
uncharged form of the toxin could penetrate the myelin sheath 
more readily than the cationic form could.
Quantitative studies of TTX's actions are sparse; however, 
the following data has accumulated; the blocking action of TTX 
has a positive thermal coefficient and the dose-response data for
8TTX block is a simple adsorption isotherm, indicating one TTX
molecule hinds reversibly to its receptor to produce a fraction
of the inhibitory effect (72); 120 molecules of TTX are bound 
2
per p of cat lateral geniculate nucleus, where TTX has a diffusion 
coefficient of 4 x 10”^ cm2/sec, and a time constant for clearing 
by the bloodstream of 2 hours (75); only 15 M X  sites per p2 were 
found by Narahashi et al.(74) in lobster giant axons. This could 
represent a significant difference between the biochemical 
composition of the cell membranes in the central nervous system of 
vertebrates and the peripheral system of invertebrates. This would 
appear to agree with the finding by Koizumi et al.(75) that spinal 
neurons are more sensitive to M X  than are motor axons.
Although one of the most potent nonprotein toxins known, 
surprisingly little is known about the biochemical mechanisms 
involved in tetrodotoxication.
Cheymol et al.(46) reported low levels of tissue culture 
(HeLa cells) toxicities for STX and TTX. It would be imprudent, 
however, to interpret this finding to mean that the toxins do not 
affect normal nerve and muscle cell metabolism. TTX does not affect 
respiration of rat brain cortex slices or the active transport of 
amino acids or phosphate into these brain cells (76). The 
(Na+-K*)-activated ATPase activity of rat brain homogenates is not 
inhibited by TTX (77). The activity of this enzyme in toad bladder 
homogenates is not affected by TTX although the toxin blocked 
active sodium and potassium ion transport in the intact bladder 
(7s, 79). Marumo et al. (79) found that TTX depressed toad bladder
9membrane oxygen consumption and slightly suppressed state IV 
respiration in rat liver mitochondria. They concluded that TTX 
inhibited active ion transport across the toad bladder by inter­
fering with the energy generating properties of the 
mitochondria.
In contrast, Swanson (60) concluded that the active 
transport and energy producing processes of cerebral cortex slices 
were not inhibited by TTX.
Kuriaki and Nagano (8 1) reported that tissue respiration 
and dehydrogenase (unspecified) act ivity in cock and mouse brains 
were inhibited by low toxin levels but stimulated by higher con­
centrations. They found choline acetylase to be the most 
sensitive enzyme inhibited by TTX. Cytochrome oxidase and acetyl­
cholinesterase were inhibited by higher concentrations 01 TTX. 
Nakazawa and Ogura (82), however, found that cytochrome oxidase 
was not affected by TTX. Prior injection of cytochrome C is said 
to have a sparing effect on mice, subsequently injected with 
TTX (8 5).
Oxygen consumption of frog nerves (27) and slices of rat 
brain and liver (82, 84) were not inhibited by TTX. Brain and 
liver oxidation of pyruvate and glutamate were unaffected by TTX 
(82). Aldolase efflux from rat diaphragm muscle cells, an index 
of membrane permeability, was unaffected (85).
Pullman et al. (86) found that 25 nM TTX produced a 
selective increase in sodium excretion by dog kidneys, whereas 
potassium and magnesium excretion were increased much less.
10
They suggested that the response might he due to vascular effects 
of TTX or to a direct action of the toxin on the sodium transport 
system, implying that the kidney sodium transport system might he 
similar to the nerve membrane transport system.
Tarby et al. (87), from an investigation of the effects of 
TTX on impedance in normal and asphyxiated cerebral tissues, con­
cluded that TTX affects post-asphyxial tissue impedance changes 
through a direct action on the cell membrane. They felt that 
calcium, on the other hand, acted on extracellular macromolecules 
in producing its effects on impedance changes.
TTX produces a hypoglycemic response in animals and humans 
(88) and acts synergistically with insulin to increase glycogenosis 
in isolated rat diaphragns (89).
TTX reportedly delays blood clotting markedly (90). Inaba 
demonstrated (91) that low doses of TTX enhanced coagulation while 
larger doses markedly inhibited the process. These results could 
not be demonstrated in vitro.
Ohnishi and Ishida (92) claimed that TTX could chelate calcium 
and interpreted this to indicate a possible mechanism of the toxin’s 
action. They postulated that TTX might forn a complex with membrane 
phospholipids and calcium ions. Presumably, this complex would 
maintain the membrane in a "resting* conformation and would be 
resistant to the "active* conformation transition. It was subsequently 
shown by Hopkins and Herbst (95) that the chelation observed by 
Ohnishi and Ishida was attributable to the presence of citrate in 
the commercially available TTX preparation. Furthermore, STX was 
found to possess no calciura-chelating activity.
11
Caraejo and Villegas (94, 95) have studied the interactions 
of TTX with different lipids. They found that TIX, silt hough not 
tetrodonic acid (non-toxic derivative of TTX) produced expansion 
of monolayers formed from nerve membrane lipids, and monolayers 
composed of the nonpolar fractions from these membrsmes. They 
suggested that TTX specifically interacted with the cholesterol 
present in nerve cell membranes. The functional groups of TTX 
might be bound to the hydroxyl and csirboxyl groups of the lipids 
by means of coulombic forces, charge-dipole, or dipole-dipole bonds. 
It was suggested that cholesterol might be part of the sodium path­
way in the axolemma and that TTX could close this channel by its 
interaction with cholesterol and possibly other membrane lipids. 
Such an explanation fails to account for the lack of effect of TTX 
on non-excitable cells, for its specificity, and does not at all 
explain why nerves of Taricha and puffer fish are resistant to the 
blocking actions of TTX.
Cockerill and Polya (9 6) claim to have demonstrated a 
polymerizing effect for TTX on •structural" proteins isolated from 
sheep brain. They have presented chromatographic evidence showing 
that TTX has no effect on "structural* protein polymers, while 
monomers of these proteins are rapidly polymerized in the presence 
of 60 pM TTX. They attempted to correlate these observations with 
the cholinesterase activity known to be present in the "structural" 
proteins; however, the effects of TTX on this enzyme's activity 
was reportedly quite variable. They posed the question of whether 
the toxin inhibits this, or some other membrane enzyme activity 
directly, or indirectly, through an effect on the membrane segments
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regarded, as the matrices for enzymatic activity.
Johansson and Thesleff (97) have completed a comparative 
study of the effects of TTX and phoBpholipase C on spike 
generation in a number of muscle tissues. Both agents were 
inactive on those muscles in which action potential generation 
does not depend upon sodium influx. Muscles blocked by TTX were 
also blocked by phospholipase C. They suggested that phospholipase 
C Interferes enzymatically with the function of the membrane 
channels which carry sodium during excitation. The presence of TTX 
failed to protect a susceptible cell against phospholipase C, 
suggesting that a strict molecular identity does not exist for the 
sites acted upon by TTX and those affected by phospholipase C.
These findings fail to explain why squid giant axons, which are 
blocked by TTX, are not blocked by phospholipase C. Perhaps the 
sodium carrying sites in nerve and muscle membranes are not 
chemically identical or that the muscles studied have other 
properties in common besides whether or not action potential 
generation is dependent upon a selective sodium influx?
TTX, as was true for STX (47), influences the light 
scattering and birefringence changes occurring in nerve membranes 
during excitation, implying an interaction with the conformational 
transitions believed to take place within the membrane concomitant 
with excitation.
While no direct evidence for the inhibition of the 
acetylcholine (ACh) - acetylcholinesterase (ACh-E) system by TTX 
is available (98-101), there is some indirect evidence that this
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system is, in some way, involved in the blocking actions of TEC. 
This evidence will he discussed later in this manuscript.
Bole of Contractile Proteins 
in Electrically Excitable Cells
The presence and function of contractile proteins in muscle 
cells has been long known and elegantly described by Szent-GyiJrgyi 
(102)^ Huxley (103), Poglazov (104), and Perry (105), to mention 
only a few.
Muscle contraction is triggered by entry of calcium ions 
into the myofibrils from the sarcoplasmic reticulum. Within the 
myofibrils are act in and myosin filaments, bridged by ATP. The 
entering calcium ions activate the ATPase activity of the myosin 
filaments, resulting in rupture of the actomyosin bond, and 
produce, in an as yet unknown manner, a pivoting of portions of 
the myosin filaments, resulting in a ratchet-like movement of 
actin filaments pant myosin filaments, or a so-called "sliding 
filament" reaction. The consequent relative positional changes 
of actin and myosin filaments are responsible for the overall 
shortening of the muscle fibers that occur concomitant with con­
traction (see 103 for review).
Contractile proteins similar to actoiqyosin have been 
reported to be present in mitochondria (106, 107)j however, these 
findings have recently been questioned by Bemis et al.(108).
Actomyosin-like proteins have also been isolated from 
slime mold membranes (109, 110, 111), sea urchin flagella (112), 
blood platelet membranes (113-118), crayfish ventral nerve cords 
(119), and cat and rat brains (120).
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Actin-like proteins have heen isolated from Tobacco Mosaic 
Virus (121), human ascites tumour cell membranes (122), sea urchin 
flagella (12J), mitotic spindle apparatus (124), and neuronal 
microtubules and neurofilaments (110, 125, 126).
Idbet (127) first suggested, based on his studies of calcium- 
activated ATPase activity of squid giant axons, that myosin-like 
proteins might be associated with conduction of nerve impulses. 
Bowler and Duncan (119) and Duncan (128) later developed the concept 
of an ATPase "raechanoenzyme* as the regulator and perpetrator of 
electrical excitability in nerve and muscle cell membranes. 
Alternatively, it was suggested by Germain and Proulx (129) and 
independently by Kadota et al. (15°) that magnesium-or calcium- 
activated ATPase activity present in isolated synaptic vesicles 
might function in storage and release of transmitter substances, 
notably, acetylcholine.
Tasaki (1J1) has developed a "physico-chemical* theory to 
explain the molecular events occurring during excitations
The excitable membrane...is visualized as a 
macromolecular complex of proteins and phospho-lipids.
A relative excess of fixed negative charge at the external 
layer of the membrane confers cation-exchange properties 
on the system. Interactions between this macromolecular 
system and its ionic environment may be thought of in 
terms of direct effects within the cation-exchange 
process, as well as indirect effects on the underlying 
macromolecular structure.
The process of excitation involves a rapid, 
reversible cation-exchange process involving transitions 
between "two stable (conformational) states" of the 
membrane macromolecules. In the resting stable state, 
the anionic sites in the membrane are occupied primarily 
by divalent cations derived from the external medium; 
in the excited stable state these sites are occupied 
predominantly by univalent cations. The conformation 
of the membrane macromolecules and the properties of
the cation exchanger are determined primarily 
by the univalent/divalent cation ratio within 
the membrane.
When an outward electric current is 
delivered to the axon membrane, the excitation 
process is triggered by the transport of 
internal univalent cations into the membrane.
These univalent cations are capable of competitive 
displacement of divalent cations from the 
anionic sites of the membrane macromolecules.
The continued displacement of the divalent 
cations by cooperative processes results in 
an increase in the univalent/divalent cation 
ratio, and produces a conformational change 
of the membrane macromolecules.
The difference in macromolecular 
conformation in the excited and resting 
states is responsible for the spread of the 
excitation process along the axon membrane.
When a limited area of the membrane is transformed 
into it8 excited^conformation, a local circuit is 
effected! current is directed inward through 
the excited area and outward through the resting 
regions. The internal cations which are driven 
into resting regions of the membrane by the 
outward-directed currents convert these regions 
to new excited patches; eventually, if the 
initial excited area is large enough, the entire 
membrane is converted from the resting stable 
conformation to the excited stable conformation. 
This conformational change is exothermic and is 
accompanied by a large increase in membrane water 
content and in the density of the charged sites 
available for trans-membrane ion transfer; 
consequently, there is a large increase in 
membrane conductance and a large change in 
membrane potential during excitation.
The increase in membrane conductance 
during excitation is associated with an increased 
interdiffusion of cations across the membrane.
In the absence of a (net) membrane current, the 
external cations are transported into the axon 
interior, and simultaneously, the internal cations 
are transported through the membrane into the 
external medium. This increased interdiffusion 
gradually alters the ionic milieu within and near 
the membrane. The change in the ionic milieu is 
responsible for the gradual alteration in the 
physicochemical properties of the membrane during 
excitation.
SXcitationlis terminated when divalent 
cations derived from the external medium once again
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form stable complexes with the fixed anionic 
sites. This is associated with a reduction in 
the univalent/divalent cation ratio in the 
membrane macromolecules and a return of 
macromolecular conformation to that of the 
resting state. The process of transition 
from the excited to the resting state is 
endothermic.
Since the presentation of Tasaki's theory, much, experimental 
evidence in support of it has accrued. The concept of biological 
membranes consisting of protein-phospholipid subunits is becoming 
widely accepted (1J2-1J4). Conformational changes occurring in 
electrically excitable cell membranes during conduction seem certain 
in light of physical changes observed in membranes concomitant with 
conduction. Namely, changes in light scattering, birefringence, 
fluorescence, and infrared emission have been observed in different 
nerve cells in association with electrical activity (47, 155, 1356).
A salient feature of these physical changes has been the observation 
by Cohen et al. (47) that TTX and. STX do affect them.
A major effort of this thesis was devoted to discovering 
whether the toxins had. any effects on contractile protein activities; 
assuming that membrane located contractile proteins might play a 
major role in conformational changes taking place in excitable 





Protein concentrations were determined by the methods of 
Lowry (157), Biuret (156), or ultraviolet absorption (159).
Bovine serum albumin (Armour Pharmaceutical Co.) was used in 
constructing standard curves.
Three different colorimetric methods were used in estimating 
inorganic phosphate concentrations! Fiske-Subbarow (140), Marsh 
(141), or a butyl acetate extraction method devised by Wahler and 
Wollenberger (142). Fisher Primary Standard KH^PO^was used in 
constructing standard curves.
Saxitoxin determinations were performed according to the 
mouse bioassay method of Schantz et al. (145) by intraperitoneal 
injection into mice weighing between 18 and 22 g. One mouse unit 
(MU) is that amount of toxin required to kill a mouse in 15 minutes, 
as defined by Sommer and Meyer (51), and is equivalent to 0 .1 8 pg 
of purified STX (14J).
An alternative bioassay procedure for STX was sought, 
employing Ohironomus thummi larvae (generously donated by Dr. Arnold 
S. Dion, formerly at the Department of Biochemistry, University of 
New Hampshire). Paraffin wells of 1 .0 cm diameter were made by 
dripping melted candle wax onto glass microscope slides. Individual 
insect larvae were placed in these wells and bathed in toxin 
solutions in 0 .2 - 0 .5 ml and observed for signs of paralysis and
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death. Curiously, while some of the larvae were paralyzed by 
STX, none died. Similar findings for the effects of TTX on 
insects were reported by Williams (144).
A chemical method for STX quantitation (145) was modified 
in order to utilize ths increased sensitivity of the Beckman IXJ-2 
Spectrophotometer (the original procedure employed larger volumes 
and were measured in a Bausch & lomb Spectronic 20). Toxin 
solutions (0.1 ml) were mixed with 0 .5 ml 5.6 % NaDH and 0 .5 ml 
picric acid solution which was made by dissolving 1.J5 g picric 
acid in 100 ml 0.04 N NaDH. The mixture was incubated 20 minutes 
at 58°C, after which time the resulting yellow color was measured 
at 510 “V- Purified STX (courtesy of Dr. Edward J. Schantz,
Ft. Detrick, Md.) was used in constructing standard curves.
2. Thin-layer Chromatography and Electrophoresis 
Cellulose thin-layer plates were prepared by shaking 75 ml 
distilled water and 50 g Whatman Cellulose Powder (CC-41) in a 
500 ml Erlenmeyer flask and applying the slurry to five 20 x 20 cm 
glass plates with a Desaga Thin-layer Spreader (Brinkmann 
Instruments, Inc.) set at O .25 mm.
STX and related guanidine derivatives were dissolved in 
either water or in 10 % isopropanol containing 1 % HC1, spotted on 
cellulose plates and developed in the solvent systems described 
in Table 1.
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Table 1. Solvent systems examined for the thin-layer chromatographic 
separations of STX and related compounds. See Appendix, Table Ai.
Solvent Composition (by volume)
Reference
▲ n-butanol(6 0), acetic acid(l5), water(25) 146
B n-butanol(35), pyridine(35)* water(35) 146
C iso-propanol(IOO), ammonia(5)» water(lO) 146
D n-amyl alcohol(2l), pyridine(42), water(57) 146
E diethylene glycol monoethyl ether(70), 
propionic acid(l5 ), water(l5), saturated 
with NaCl 147
F phenol(80), water(20) 14
G t-butyl alcohol(5 0), acetic acid(25), water(25) 14
H t-amyl alcohol(35), pyridine(35), water(30) 14
I n-butanol(50), pyridine(12.5 ), acetic acid(12.5) 
water(25) 148
J n-propanol(6 0), acetic acid(15), water(15) 148
Thin-layer electrophoresis was performed on cellulose plates 
in a Gelman Electrophoresis Chamber. After the plates had been 
spotted with the test compounds they were either sprayed with the 
electrophoresis buffer or placed in chromatography chambers containing 
the buffer, developed up to the origin, then inverted and developed 
back to the origin. The saturated plates were then used for electro­
phoresis. Plates were run with a constant voltage of 250 - 350 V for 
33 - 60 minutes in the buffer systems described in Table 2. Migration 
was cathodal.
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Table 2. Buffer systems examined for the thin-layer electrophoretic 
separations of STX and related compounds. See Appendix, Table A2.
Solvent Composition (by volume) Reference
A pyridine(5t), acetic acid(lO), water(487) 149
B sulfosalicylic acid(0 .065 M, pH 5.5 with 
NaDH) 150
C citric acid (0.07 M, pH 5.5 with NaDH) 151
D formic acid (1.0 N, pH 2.0 ) 152
E acetic acid (1.0 N, pH 2.5) 152
Following either thin-layer chromatography or electrophoresis, 
plates were air dried in a hood and then sprayed with various reagents 
to detect the samples. The alpha-naphthol diacetyl reagent described 
by Roche et al.(155) was used for detecting N, N-disubstituted and 
monsubstituted guanidines. The Jaffe reagent (154) vias used for 
detecting creatinine, glycocyamidine, and lactams of alpha-guanidino 
acids. The Sakaguchi reagent (155) detected the presence of mono­
substituted guanidines. Monosubstituted, N,N'-disubstituted, and 
N-substituted-5-nitroguanidine compounds were detected by the Weber 
reagent (155). The Benedict-Behre reagent (156 ), which detects active 
metbyl, methylene, methine groups, creatinine, and other nucleophiles 
was also employed.
Discontinuous polyacrylamide gel electrophoresis of proteins 
was performed with the Canalco gel electrophoresis power supply,
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buffer chamber, and reagents. A 7 %» pH 9*5 standard gel solution 
was used according to the manufacturer's suggestions. Electrophoresis 
was carried out at 4 ma per gel in the standard tris-glycine buffer 
and stained with aniline blue black (0.5 % in 7 % acetic acid).
Gels were destained by shaking overnight with 7 % acetic acid, 
followed by electrophoretic destaining, also in 7 % acetic acid, 
carried out at 10-12 ma per gel. Gels were stored in 7 % acetic acid.
3. Column Chromatography 
Glass chromatography columns (handmade or purchased from 
Pharmacia Fine Chemical, Inc., and from Ace Glass Inc.) were used 
for performing separations of the following types: molecular sieve
(Sephadex and Sepharose , Pharmacia), ion exchange (DEAE-Sephadex, 
Pharmacia; DEAE-Cellulose, Schleicher & Schuell Co.; Dowex, BioRad 
Laboratories; Rexyn 102 and Rexyn 203, Fisher Scientific Co.), and 
adsorption (alumina, Harshaw Chemical Co.).
Sephadex gels were prepared according to the manufacturer's 
suggestions. Sepharose gels were washed thoroughly before use to 
free them of preservative (sodium azide).
Sephadex ion exchange resins were pre-swollen in water prior 
to acid-alkali cycling. All ion exchange resins were cycled through 
at least three complete cycles of 0,5 N NaOH - water - 0.5 N HC1 - 
water, performed on a Buchner funnel, followed by washing with the 
starting buffer and decantation of fines.
Coarse-powdered, catalyst grade, active alumina was prepared 
according to Schantz et al. (15). The activated alumina was stored in 
glass-stoppered bottles, sealed with paraffin until just prior to use.
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Gradient-generating devices were constructed of polypropylene 
graduated cylinders, Tygon tubing, polyethylene tubing, threaded 
plastic joints, and polyethylene ball-and-socket tube connectors 
with steel spring-clamps, all patterned after a design suggested 
by Dr. Gerald L. Klippenstein, University of New Hampshire (Fig. 1).
Column chromatography was performed in a 4°C walk-in, 
fractions being collected by a volume-measuring device (ISCO).
4. Biochemical Preparations 
Mitochondria
Mitochondria were isolated from livers and brains of Sprague- 
Dawley male rats (Goftaoor Farms) according to the procedures of 
Johnson and Lardy (157) and Basford (15®)* for liver and brain 
mitochondria, respectively.
Animals were stunned, decapitated and exsanguanated into a 
sink for 5 minutes. Tissues were rapidly excised, minced with 
scissors, and homogenized with 2 volumes of 0.25 M sucrose, 10 mM 
Tris-HCl, pH 7.4, 1 mM BETA in a Potter-Elvehjem homogenizer 
(0.006 inch clearance) by twelve complete passes of the pestle at 
600 rpn. Homogenabes were transferred to fyrex glass centrifuge 
bottles, diluted to 10 volumes sucrose solution per g tissue, gently 
mixed, and centrifuged 15 minutes at 460 g in a FE-2 centrifuge. 
Supernatants were transferred to polypropylene centrifuge tubes 
and centrifuged 20 minutes at 9,500 g in a Sorvall RC-2 centrifuge. 
The mitochondrial pellets were re-suspended in minimal volumes of 








Fig. 1. Gradient-generating device for column 
chromatography.
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11 minutes at 9,000 g. Pellets were gently homogenized with an 
ice-filled test tube in minimal volumes of sucrose buffer. This 
step was repeated and mitochondria were finally precipitated by 
centrifugation at 15,000 g for 15 minutes.
Brain mitochondria were isolated as above, except 0.4 M 
sucrose replaced 0.25 M sucrose in the buffers.
Microsomes
Rat brain microsomes were prepared by the method developed 
by Skou (159). Brains were rapidly removed from decapitated 
animals, washed in O.25 M sucrose, 5° “M histidine, pH 6.8,
5 mM EETA, 0.1 % deoxycholate, trimmed of meninges and blood vessels, 
and homogenized with 10 volumes of the above sucrose buffer in a 
Potter-Elvehjem homogenizer. Homogenates were centrifuged 15 
minutes at 10,000 g to pellet mitochondria, nuclei, and cell 
debris. Supernatants were centrifuged 1 hour at 20,000 g to 
precipitate crude microsomes, which were resuspended in 1 /2 the 
original volume in a solution containing O.25 M sucrose, 50 mM 
histidine, pH 6.6 , 1 mM EDl'A, 0 .0 5 % deozycholate. These sus­
pensions were centrifuged 50 minutes at 85,000 g in a Beckman 
L-2 Ultracentrifuge, using the # 40 rotor. The resultant pellets 
constituted the purified microsomal preparations.
(Nat-K4)-Activated Adenosine Triphosphatase
Purified microsomal preparations were either used directly 
for assays of (Na+-K+)-activated ATPase activities or purified 
further, based on modifications of methods described by
Mcllwaln et al. (160), Samson and Quinn (161), Thompson (162), and 
Lieberraan et al. (16J), and presented In Figure 2.
Hat Brains (fresh or thawed after liquid storage)
I
Mince and homogenize in Potter-Elvehjem with 10 -volumes of distilled 
water or 0.25 - 0 .3 2 M sucrose, 10 mM Tris-HCl, pH 7.4
I
Centrifuge 10 - 13 minutes at 1,000 g
 1




Centrifuge supernatant 1 hour at 144,000 g Discard
I
pellet
Microsomal pellet (Na+-K*)-activated ATPase Discard
supernatanti
Fig. 2. Boutine method of preparing rat brain microsomal (Na+-K+)- 
activated Adenosine Triphosphatase.
A “purified* brain microsomal (Na+-K+)-activated ATPase 
preparation was obtained, patterned after the method described by- 
Israel and Salazar (164). Brains were homogenized 1 minute at the 
lowest speed of an Osterizer in 0 .2 3 M sucrose, 3 mM SETA, 10 mM 
Tris-HCl, pH 7.0, followed by centrifugation 10 minutes at 10,000 g. 
The pH of the supernatant was adjusted to 3*0 by addition of 1.0 M 
acetate buffer, pH 4.3, and allowed to stand 10 minutes, after which 
time it was centrifuged 3° minutes at 12,000 g. The pellet was
26
resuspended in 1/10 the original volume with O .25 M sucrose,
3 mM EDTA, and the pH was adjusted to 7.5 with 2 .0 M Tris. The 
preparation may then he stored for several months at -20°C or 
processed directly hy centrifugation for 1 hour at 65,000 g.
The pellets were resuspended in O.25 M sucrose, 10 mM Tris-HCl, 
pH 7.4, and centrifuged 5 minutes at 5,000 g. The supernatant 
was again centrifuged 1 hour at 65,000 g and the pellet resuspended 
in O.25 M sucrose, 1 mM BETA, 10 mM Tris-HCl, pH 7.4 to a final 
concentration of about 50 mg protein per ml. To this was added 
a solution of 1.3 M Nal, 1 mM BETA, 10 mM Tris-HCl, pH 7.4 and the 
suspension was centrifuged 1 hour at 65,000 g. The pellet was 
resuspended to a final concentration of 12 - 15 mg protein per ml 
in sucrose, BETA, Tris. The preparation could be used directly 
or stored at -20°C for at least 3 months without significant loss 
of enzyme activity.
Mg++-Activated Microsomal Adenosine Triphosphatase 
That quantity of ATPase activity remaining in microsomal 
preparations in the presence of ouabain (10"5- 10“4 M) or in the 
absence of sodium is attributed to the Mg^-activated ATPase. A 
modified microsomal preparation similar to that described by Bowler 
and IXincan (165) for Mg^-activated ATPase (Fig. 3)» or a procedure 
similar to that described by Nakamaru et al. (166-168) for a 




Homogenize in Potter-Elvehjem with 5 volumes O .25 M 
sucrose, 50 mM histidine, pH 7.25, 1 mM EDTA.
]
Dilute to 10 volumes with above solution, centrifuge 
10 minutes at 2,000 g
Centrifuge supernatant 20 minutes at 12,500 g. 
Bepeat.
Centrifuge supernatant 1 hour at 107,000 g to 





Fig. J. Bat brain Mg4+-activated microsomal ATPase 
preparation modified after Bowler and Duncan (165).
Bat Brains
Homogenize in Potter-Elvehjem with 10 volumes 0 .J2 M 
sucrose, 5 ®M Tris-HCl, pH 7.2
Centrifuge 10 minutes at 1,500 g
\r
Centrifuge supernatant 1 hour at 17,000 g
1—  ■ -
Centrifuge supernatant 1 hour at 64,000 g
Homogenize pellet in 5 nM Tris-HCl, pH 7.2.
Add equal volume 0.2 i> digitonin to aid 








Fig. 4. Brain microsomal (Mg++-Ca++)-activated ATPase 
isolation procedure modified from Nakamaru et al. (166-168).
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Crayfish Ventral Nerve Cord "Contractile Protein"
Ventral nerve cords from Cambarus sp. (Connecticut Valley 
Biological Supply Co.) were excised from animals that had been 
anesthetized by ice bath immersion and prepared by the method of 
Bowler and Duncan (119) by homogenization in O.25 M sucrose, 1 mM 
EDTA, 50 mM Tris-HCl, pH 7.2 followed by centrifugation 10 minutes 
at 2,000 g. The supernatants were centrifuged 20 minutes at
12,000 g, twice in succession. The resultant supernatants were 
either diluted with O.25 M sucrose, JO mM Tris-HCl,pH 7.2 to an 
absorbance, at 410 mp, of 0.4 - 0 .6 and used for superprecipitation 
studies, or pelleted by centrifugation 1 hour at 145,000 g and 
resuspended in 50 mM Tris-HCl, pH 7.2 for ATPase activity assays.
Actomyosin and Myosin 
Actomyosin was prepared from rat para-vertebral and hind leg 
muscles according to Szent-Gyorgyi (102). Freshly excised muscles 
were washed in Kreb's Mammalian Binger (169), minced, and homogenized 
in a Sorvall Omni-Mixer at maximum speed for 50 seconds with 5 volumes 
0.6 M KC1, 40 mM NaHCO ,^ 10 mM NagOO ,^ pH 8 .2. The suspension was 
stirred 16 hours at 4°C, centrifuged 10 minutes at 10,000 gj the 
supernatant decanted and centrifuged 1 hour at 60,000 g. The 
resultant supernatant was diluted with water to reduce the KC1 to 
0.1 M and the pH adjusted to 6 .5 by slow addition, with stirring, 
of O.125 M acetate buffer pH 4.9. The suspension was stirred 1 hour 
at 4°C and the crude actomyosin precipitate was collected by 
centrifugation at 12,000 g for 5 minutes. The pellet was resuspended 
in 0.6 M KC1, 5° mM Tris-HCl, pH 7.2 and diluted, by addition of
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water, to a final KC1 concentration of 0 .1 M. The suspension 
was stirred 1 hour at 4°C, the pH lowered to 6 .5 and the 
actomyosin collected by centrifugation 5 minutes at 12,000 g.
The final actomyosin pellet was either used directly or further 
purified by passage through columns of Sepharose 4B equilibrated 
and eluted with 0.6 M EC1, 10 - 50 mM Tris-HCl, pH 6 .8 -8.5 .
Myosin was prepared from actomyosin according to the 
procedure suggested by Adelman et al. (110) in which actomyosin 
solutions were passed through columns of either Sephadex G-200 or 
Sepharose 4B, equilibrated and eluted with 0.6 M KC1, 10 mM Tris- 
HCl, pH 8.0, 0 ,5 mM ATP. Myosin is dissociated from actin in the 
presence of AEP and is eluted in the first few fractions of the 
columns. Free actin is not eluted from the columns until much 
later.
Alternatively, myosin was prepared directly from rat 
muscle according to the method of Asai (170). Minced muscle was 
homogenized with 5 volumes of O .57 M EC1, 5° mM histidine, pH 6 .8, 
0.4 mM ATP. The homogenate was centrifuged 10 minutes at 9 ,000 g 
and the supernatant diluted with 9 volumes of water. The crude 
myosin precipitate was collected by centrifugation at 25,000 g 
for 20 minutes and resuspended in 0.6 M EC1, 25 mM histidine, 
pH 6.8. The suspension was diluted with an equal volume of water 
to precipitate actomyosin which was collected by centrifugation 
for 2 hours at 50,000 g. The supernatant was diluted with 7 volumes 
of water and the myosin precipitate was collected by centrifugation 
at 25,000 g for 20 minutes. The myosin was resuspended in 0 .6 M EC1
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and. diluted, with an equal volume of water as before to remove any 
remaining actomyosin, which was removed by centrifugation. Again 
the supernatant was diluted with 7 volumes of water and the final 
myosin precipitate was collected by centrifugation at JO,000 g for 
20 minutes. Myosin was suspended in 0 .6  M KC1, JO mM histidine, 
pH 6 .8 or in 50 % glycerol, 0.6 M KC1, 25 mM histidine, pH 6 .8 for 
storage at -20°C. Myosin stored in glycerol was recovered by 
dialysis against 10 volumes of water and centrifugation of the 
precipitate at JO,000 g for 20 minutes.
▲ third method of preparing myosin, based on Baril's 
procedure (171) was also employed. Tissue was washed with 0.04 M 
KC1, 6 .7 mM potassium phosphate buffer, pH 7.0 and homogenized in 
J -5 volumes of the same solution, followed by stirring in an 
additional J - 5 volumes of the buffer for 90 minutes. The 
suspension was centrifuged 20 minutes at 10,000 g and the super­
natant discarded. The pellet was homogenized in 5 volumes of 
0 .0 2 M Na^ PgOy, pH 9.5, 1 oM MgCl£ and stirred for 90 minutes 
following the addition of 5 more volumes of pyrophosphate buffer. 
This suspension was centrifuged 4 hours at 145,000 g in a Beckman 
L-2 Ultracentrifuge. The supernatant was concentrated by dialysis 
against 20 % polyethylene glycol (Carbowax, 20,000 m.w.). Myosin 
was rinsed out of the dialysis sacs with 0.02 M Na F^ O^ ,^ pH 8 .5  
and passed through columns of Sephadex G-200 or Sepharose 4B, 
equilibrated and eluted with pyrophosphate buffer, to remove 
contaminants derived from the Carbowax.
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Myosin preparations ware further purified by ion exchange 
chromatography on columns of DEAE-Sephadex A-50 or DEAE-Cellulose, 
type 20 (Schleicher & Schuell). Columns were eluted with either a 
step gradient, according to Baril (1?1)» or a linear gradient 
described by Richards et al. (172), or that of Morey (175)> sad. 
shown in Tables 5 and 4.
Table 5. Step-wise gradient elution scheme of Baxil (171) for 
fractionation of myosin on columns of KEAE-Sephadex or DEAE-Cellulose.
Fraction Buffer Composition (pH 8 .5 ) Identity of Fractions
I 0 .0 2 0 M Na4P20? non-acidic proteins
II O.OOJ M NaAP20?, 0.125 M KC1 myosin-RNA complex
III 0.005 M Na4P20?, 0 .1«0 M KC1 rayosin-RNA complex
IV 0.010 M Na4P207. O.56O M KC1 "pure* myosin
V 0.020 M Na4P20?, 0.900 M KC1 ribonucleoprotein(s)
Table 4. Linear, continuous gradient elution schemes of Richards 
et al. (172) and Morey (175) f°r myosin fractionation on LEAS columns.
Buffer Composition in 
Mixing Chamber A
Buffer Composition in 
Chamber feeding into A
O.15 M K-phosphate buffer O.15 M K-phosphate 




0.04 M Ite^ PgO , pH 7.5 0.04 M Na,I> 07, pH 7.5
1 .0  M KC?
Morey
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Vertebrate Brain "Contractile Protein*
The methods previously described for the preparation of 
actomyosin and myosin from rat muscle were also used to extract 
similar proteins from brains of rat, bovine, rabbit, and sheep 
origin. The application of Szent-Gybrgyi's procedure to rat and 
cat brain has already been reported by Puszkin et al. (120).
5. Light Scattering Determinations
Mitochondrial Swelling Measurements 
Turbidity changes associated with swelling and contraction 
of mitochondria were measured at 520 top. in either a Beckman DU-2 
Spectrophotometer or a Cary 15 Recording Spectrophotometer, equipped 
with a circulating water bath lor maintaining constant sample chamber 
temperatures. Mitochondria were incubated in either the medium 
described by Schwartz et (174), consisting of 0 .107 M KC1,
17 mM Tris-HCl, pH 7.4, or that -used by Hockley (175)» which contained
O.25 M sucrose, 5 ~ 1° Tris-HCl, pH 7.4. Reactions were initiated 
by addition of mitochondria to cuvettes containing the incubation 
medium.
Actomyosin Superprecipitation 
The ATP-induced superprecipitation, or syneresis, of actomyosin, 
crayfish ventral nerve cord "contractile protein", and vertebrate 
brain "contractile proteins- were observed by measuring the increase 
in absorbance (410 mp.) of a contractile protein solution that occurred 
following the addition of ATP. These turbidity changes were recorded 
with a Cary 15 Recording Spectrophotometer. .fThe reaction medium
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described, by Bowler and Duncan (119), which contained JO mM Tris- 
HCl, pH 7.2, 6 mM MgCJg, or that used by Puszkin et al. (120), 
composed of 0.1 M KC1, 10 mM Tris-HCl, pH 6.8, J mM MgClg were 
routinely used. Heactions were initiated by addition of ATP.
6. Enzyme Assays
Acetylcholinesterase
A titrimetric method described by Nachmansohn and Wilson (176)
was used for measuring acetylcholinesterase (ACh-E) activity.
10 ml of 0 .1 M NaCl, 4 - 40 mM MgClg, pH 7.4, and 250 - 500 ug
acetylcholine chloride (ACh) was placed in a JO ml beaker. The
reaction mixture was stirred with a magnetic stirring device and
the pH monitored with a pH meter. The reactions were initiated by
adding 50 - 100 pg ACh-E (5.75 - 7.50 units, horse serum Type IV,
Sigma; 1 unit is capable of hydrolyzing 10.1 pg ACh per minute at 
n -4
pH 7.4 and 57 C). J x 10 N NaOH was added from a microburette 
at 15 second intervals to maintain the pH constant at 7.4. Heactions 
were studied at room temperature (25-25°C). Activity was calculated 
by measuring the volume of alkali added to the reaction mixture at 
one minute intervals during the course of the reactions (15 - JO 
minutes).
Mitochondrial Adenosine Triphosphatase(s)
Isolated mitochondria were suspended in O.25 M sucrose,
10 mM Tris-HCl, pH 7.5 and- assayed for ATPase activity by the method 
of Stoppani and Vallejos (177). The reaction mixture contained, in 
a final volume of 1 .0 ml, 5 mM ATP, O .25 M sucrose, 50 mM Tris-HCl,
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pH 7.5, 2 mM MgClg (for determining "latent* ATPase activity)
and/or JO mM KC1 (for determining non-latent ATPase activity).
It was later discovered that addition of "bovine serum albumin to
a final concentration of 0 .1 % greatly improved the activity and
reproducibility of the preparations (as suggested by Dr. Frank
Davidoff, Beth Israel Hosp., Boston, personal communication).
It was necessary to remove fatty acid contaminants from the
commercially available albumin (Armour) by dialysis against water
for 48 hours prior to use. Reaction mixtures contained 0.8 - 2.0 mg
mitochondrial protein and were initiated by addition-of ATP,
o
followed by incubation at 37 C for 15 - 3° minutes, after which 
time reactions were terminated by the addition of 1 .0 ml ice cold 
5 % perchloric acid, placed in an ice bath for 5 minutes and 
centrifuged at low speed for 10 minutes to precipitate the protein. 
Supernatants were decanted and assayed for inorganic phosphate. 
Controls containing all ingrediants minus mitochondria and zero 
time incubation assays were employed to subtract non-enzymatically 
derived inorganic phosphate.
(Na+-K4)-Activated Adenosine Triphosphatase 
Microsomal (Na^-K*)-activated ATPase activity was routinely 
measured by a method modified from Mcllwain et al. (160), containing, 
in a final volume of 1 .0 ml, 3 4IP, 100 mM NaCl, 4 mM MgClg,
30 mM KC1, 100 mM Tris-HCl, pH 7.4, and 1 - 4 mg microsomal protein. 
Reactions were initiated by addition of ATP and aillowed to continue 
at 37°C with occasional shaking; finally terminated by addition of
1 .0  ml 5 % trichloroacetic acid, followed by centrifugation and
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decantation of supernatants for inorganic phosphate analysis.
—3 "4Omission of NaCl and/or addition of ouabain (10 -10 M) was 
employed to detect phosphate liberated by non-(Na* -activated 
ATPases. Suitable controls ls^king microsomes and zero time 
incubation assays were used to subtract non-enzymatically produced 
inorganic phosphate.
An alternative, optical assay procedure (178) for measuring 
ATPase activity was also employed. This involved the regeneration 
of APP by the action of pyruvate kinase on phospboenol pyruvate (PEP) 
and the subsequent oxidation of NASI by pyruvic acid and lactic 
dehydrogenase (LEH). The reaction was followed by recording the 
decrease in absorbance (at JAO mp.) of NAEH as a function of time.
The reaction scheme of this coupled enzyme procedure is depicted in 
Figure 5* The stoichiometric relationship of ATP hydrolysis with 
NAEH oxidation permitted the results from these assays to be cal­
culated as umoles ATP hydrolyzed per unit time. The reaction 
mixture, in a final total volume of 2.5 ml, contained 10 mM .histidine, 
pH 6 - 7, or 10 mM Tris-HCl, pH 7 - 9, 100 mM NaCl (omitted for 
non-(Na4-K+)-activated ATPase determinations), JO mM NH^ Cl, J mM 
MgClg, 1 mM NAEH, 1 mM PEP, 9.4 units of pyruvate kinase, 9A  units 
of LEH, 0.1 - 4.0 mg microsomal protein, 0.1 - J.O mM ATP. Beactions 
were initiated by ATP addition and monitored at J7°C with a Cary 15
Recording Spectrophotometer. Controls lacking enzyme (ATPase),
-3 -4lacking sodium, or containing ouabain (10 -10 M) were performed. 
Reactions were allowed to proceed for 3 - 3 °  minutes.
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Mg++, Na4, NHj
1. ATP ♦ H O ------------------------------ ALP ♦ Pi
ATPase
Mg44, NH4
2. PEP ♦ ALP -----------------   » Pyruvate + ATP
Pyruvate Kinase
5. pyruvate ♦ NADH ♦ H* ---------------------- ► Lactate ♦ NAD*
LEH
Pig. 5* Coupled enzyme assay reaction scheme for optical determination 
of ATPase activity. Oxidation of NAIH was followed by observing the 
absorbance decrease of the reduced nucleotide at 540 ngi as a function 
of time.
Mg++-Activated Microsomal Adenosine Triphosphatases 
Assay systems described for the (Na4-K4)-activated ATPase 
deficient in sodium or containing ouabain were used for determining
AA
Mg -activated ATPase activities. In some cases calcium was used in 
place of, or in addition to, magnesium.
Contractile Protein Adenosine Triphosphatases 
Contractile protein ATPase activities were determined in the 
presence of 10 - 100 mM buffer (histidine or imidazole, pH 6 - 7; 
Tris-HCl, pH 7 - 9; lysine, pH 9 - 10), 1 - 4 mM CaCl2 or Mg Cl2# 
0-0.6 M KC1. Reactions were initiated by ATP addition, run at 
57°C for 5-50 minutes, and terminated by addition of TCA, followed 
by centrifugation and phosphate analysis of the supernatants.
In some cases the coupled enzyme optical assay method described 
earlier was employed with the following changest NaCl was omitted,
0.6 M KC1 was used in place of NH^ Cl, the MgClg concentration was 
reduced to 0 .2 mM, and 2 mM CaClg was added.
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7. Physiological Preparations
Mytilus Pedal Ganglion 
Mytllus edulls, the common mussel (collected at Newcastle,
N.H.) pedal ganglia were exposed by in situ dissection of animals. 
Exposed ganglia were impaled with microelectrodes containing 
5 M KOI, 1 0 - 2 2  megohm resistance, that were held in plexiglass 
holders and positioned by micromanipulators. The electrodes were 
connected to a preamplifier which was, in turn, connected to a 
Tektronix 502A Dual Beam Oscilloscope. A Grass Audio Monitor was 
also connected to the system for audial signal display. The animal 
preparation, preamplifier, and electrodes were contained in a copper 
screen Faraday Cage. Preparations were periodically bathed with 
sea water.
Mytilus Anterior Byssus Retractor Muscle 
The anterior byssus retractor muscles (ABRM's) of Mytilus 
edulis were exposed by free-hand dissection and secured to a Grass 
Tension Transducer by means of a thread tied around the distal end 
of the muscle. The transducer was connected to a Grass Polygraph 
for displaying muscle contractions, which were elicited by stimulating 
the muscles electrically by means of a Tektronix Stimulator (100 msec 
pulse width, 10 msec interval, 5 sec duration, alternating current). 
The preparations were kept moist with sea water.
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Mya Heart
Mya arenaria, the soft-shell clam (collected at Newcastle, 
N.H.) hearts were exposed by removing the left valve of the clam 
shell and retracting the gill flap ventrad. A common straight pin, 
bent to an S shape was gently positioned under the posterior region 
of the heart and connected to a tension transducer which was, in 
turn, connected to a strip-chart recorder. The preparation was 




1. Effects of Saxitoxin, Tetrodotoxin 
and Related Compounds on Mitochondria 
The well documented effects of arginine-rich histones 
(174, 179-1^2), guanidine compounds (18J, 1®4)» and polyamines 
(175) on mitochondria provided the basis for these studies. We 
hoped to either implicate or exclude the mitochondria as possible 
sites of toxin action. In addition, we wished to examine the 
effects of SIX and TTX on an isolated biological, membrane system.
Mitochondrial swelling is associated with an increased 
oxygen consumption, increased potassium efflux, and increased ATFase 
activities (for reviews see 185-187). Arginine-rich histones, 
cytochrome C, Valinomycin, para-thyroid hormone, calcium, Thyroxine, 
inorganic phosphate, and deoxycholate are a few of the agents shown 
to induce mitochondrial swelling. Agents that inhibit mitochondrial 
swelling or cause contraction are also well known, e.g., GTP, 
polyamines, guanidines, gangliosides, phosphoproteins, and Chlor- 
promazine. Accordingly, it was anticipated that STX and TTX, being 
alky 1-guanidines, might exert an inhibitory action on mitochondrial 
swelling. The experimental neurotropic drug, BW 58-271 (188), which 
is a pyrrolopyrimidine (Fig. 6 ) possessing pharmacological as well 
as structural similarities to STX and TTX was included in these 
studies.
HFig. 6. BW 58-271, 2-jnethyl, 4-benzylamino pyrrolo- (2,J-d) 
pyrimidine.
It has been reported that mitochondria bind alky 1-guanidines 
(185), thus it was of interest to determine if STX could also be 
bound by isolated rat brain mitochondria. Bat brains were fractionated 
into nuclear, mitochondrial and microsomal fractions. Each fraction 
was incubated at 57°C, 1 hour in O.25 M sucrose, 25 raM Tris-HCl, 
pH 7.4, in the presence of STX (final concentration of O.57 pg/ml, 
or approximately 2 mouse units per ml). The particles were then 
sedimented by centrifugation and the supernatants were injected into 
mice (1 .0 ml per animal). Table 5 shows the results of this study.
Table 5. Binding of STX by rat brain sub cellular fractions.
Fraction Number of mice (total of six) % STX bound
incubated surviving injection, of by fraction








It is clearly seen that the toxin apparently was bound, by both 
the nuclear and the mitochondrial brain fractions, and somewhat 
less so by the microsomal fraction.
Incubation of mitochondria in 0.107 M KC1, 17 mM Tris-HCl, 
pH 7.4 produces little change in light scattering, as can be seen 
in the controls in Figures 7, 8, and 9. The addition of 50 pg of 
arginine-rich histone produces a 55 % decrease in mitochondrial 
absorbance within 15 minutes, as previously reported (174).
STX had very little effect on rat liver mitochondria in the 
range O.J - 45.0 pM. However, 90.0 pM STX caused a 55 % decrease 
in absorbance within 15 minutes, comparable to the effects of 
arginine-rich histone (Fig. 7).
In a like manner, TTX had little influence on mitochondrial 
swelling at 5.0 - 45 pM. At 90.0 pM and at 180 pM, however, TTX 
produced a JO % and a 55 % absorbance decrease, respectively (Fig. 8).
Similarly, BW 58-271 was ineffectual at concentrations below 
60 pM, while at 120 pM, a JO % absorbance decrease was observed 
(Fig. 9).
By contrast, mitochondria incubated in O .25 M sucrose, 5 niM 
Tris-HCl, pH 7.4 undergo swelling without the addition of any agents. 
Under these conditions, the addition of arginine-rich histones 
enhances swelling (Fig. 10). As seen in Figure 10, STX retards 
mitochondrial swelling 20 - 60 % and is equally effective in doing so 













Fig. 7» Effects of STX and arginine-rich histone on rat liver 
mitochondrial swelling, (a) control, (b) 0.3 - 40.0 pM STX, (c)
50 pg histone, (d) 90.0 pM STX. 2 mg mitochondrial protein, 0.107 




Fig. 8. Effects of TTX on rat liver mitochondrial swelling, (a) 
control, (b) 3 - 45 pM TTX, (c) 90 pM TTX, (d) 180 jiM TTX. Conditions 










Fig. 9. Effects of BW 58-271 on rat liver mitochondrial swelling.
(a) control, (b) 3 - 60 >iM BW 58-271, (c) 120 jiM BW 58-271. Conditions 











Fig. 10. Effects of STX and arginine-rich histone on rat liver 
mitochondrial swelling, (a) 0.3 - 90.0 pM STX, (b) control, (c)
50 pg histone. 0.25 M sucrose, 5 roM Tris-HCl, pH 7.^ , 2 mg mitochondrial 
protein, 3*5 ">!» 25 C.
The ability of STX to promote swelling of mitochondria in 
0.1 M KC1, while actually retarding mitochondria swelling in 
O .25 M sucrose is perplexing. That relatively high toxin con­
centrations are required to affect mitochondria incubated in 0.1 
M KC1 would suggest that toxin-induced swelling might not be related 
to the physiological actions of the toxins. Suppression of mito­
chondria swelling in O.25 M sucrose by relatively low amounts of 
STX cannot be so readily dismissed. This retarding effect suggests 
that the toxin may be stabilizing the mitochondrial membranes.
Similar observations have been made for the polyamines (175).
Gallagher and Judah (189) found that neuro-muscular blocking 
agents of the curare and pyrrolizidine alkaloid type also inhibit the 
swelling of isolated mitochondria incubated in buffered sucrose.
They suggested that these agents do not cause a general increase in 
mitochondrial permeability but that they produce their effects by 
more specific mechanisms related to the positive charge carried on 
the ring nitrogen atom. They hypothesized that the alkaloids com­
pete with other positively charged compounds (e.g. NAD*) for 3ites 
in the mitochondria and actively displace them from these sites.
A similar explanation might account for the observed effects of STX 
on rat liver mitochondria swelling processes.
Bat brain mitochondria, on the other hand, when incubated in 
0.1 M KC1 underwent little swelling upon the addition of calcium 
(1-6 mM), procaine (57 mM), d-amphetamine (1 mM), or arcaine (1 mM). 
When rat brain mitochondria were incubated in 0.4 M sucrose, however, 
they responded by an increase in absorbance following the addition
of calcium ions. An increase in absorbance is associated with 
either contraction or aggregation of mitochondria. No precipitates 
formed so it is assumed that mitochondria contraction was occurring. 
Calcium, however, is a mitochondria swelling-inducing agent, thus 
no clear explanation for the observed absorbance changes induced by 
calcium can be provided. Similar effects were produced by arcaine 
and procaine. Amphetamine and TTX, however, were without effect upon 
brain mitochondria absorbance, in the absence of added calcium. 
Subsequent addition of calcium to brain mitochondria pre-incubated 
with TTX, however, appeared to indicate that TTX could inhibit the 
anomalous effect of calcium. These effects are illustrated in 
Figures 11 and 12. The calcium effect is inhibited nearly 60 # by 
60 pM TTX. That the TTX inhibitin was not due to the presence of 
sodium citrate was demonstrated by examining appropriate citrate 
controls. The amount of citrate present in 60 pM TTX was found to 
exert only a minor inhibitory effect (12 %) on calcium-induced 
mitochondrial absorbance increase.
That the TTX inhibitory effect was related to the action of 
calcium on the mitochondria is illustrated by the ability of high 
(10 mM) amounts of calcium to overcome the TEX inhibition (Fig. 1J). 
JEven at this high concentration, however, calcium does not completely 
overcome the inhibitory effects of TTX, further supporting the con­
tention that the effect of the toxin is not an artefact due to the 
presence of sodium citrate.
Arginine-rich histones enhance the activity of mitochondrial 







Fig. 11. Effects of TTX on rat brain mitochondrial calcium-induced, 
turbidity changes, (a) control, (b) 6 jiM TTX, (c) 31 pM TTX, (d)
62 pM TTX. O.iJ- M sucrose, 10 mM Tris-HCl, pH 7»^ » 0.6 mM CaCl_ 
(added at time 0), 1.2 mg mitochondrial protein, 2.5 ml, 37°
0 20 40 60
Tetrodotoxin (pM)
Fig. 12. Plot of TTX concentration versus % inhibition of the 
turbidity response of rat brain mitochondria to calcium. Conditions 























Fig. 13. Ability of calcium to overcome the effects of 62 jiM TTX 
on calcium-induced, rat brain mitochondrial turbidity changes. 
Conditions as in Fig. 11.
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compounds (185) inhibit the activities of these enzymes. It seemed 
likely that STX and TTX might also have an effect on mitochondrial 
ATPase activities.
The effects of STX on mitochondrial ATPases are shown in 
Table 6. Assays were conducted in the presence of magnesium, which 
reportedly activates "latent" mitochondrial ATPase (177). In addition, 
non-magnesium activated ATPase was also assayed. The latent ATPase 
becomes apparent in association with structural damage of the mito­
chondrial membranes. Thus a membrane-acting agent might be expected 
to increase the activity of this enzyme. The stimulatory effects of 
STX on the ATPases activities could then be explained as a result of 
the toxins interaction with the mitochondria membranes. The stimulating 
effects of STX on the ATPases activities are illustrated in Figure 14, 
from which it can be seen that O.57 pM STX enhances the activity 
nearly 20 %.
It was subsequently learned that inclusion of bovine serum 
albumin in the assay medium improved the activity and. quality of 
the preparations. When mitochondria were incubated in the presence 
of previously dialyzed bovine serum albumin (0.1 %) and assayed for 
ATPase activities, a AO % stimulation of that activity, over 



















Pig. 1^ . Plot of log STX concentration versus rat liver mitochondrial 
ATPases activities. Conditions as in Table 6.
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Table 7* Effects of STX, TTX, and arcaine on rat liver mito­
chondrial ATPases incubated in the presence of 0.1 % 
bovine serum albumin. 1.0 - 1.5 mg mitochondrial 
protein, 30 G, 0.25 M sucrose, 50 mM Tris-HCl, pH 7»5» 
30 mM KG1, 2 mM MgClg, 5 mM ATP, 1.0 ml final volume.
Saxitoxin ATPases Activities Effect Significance
(average of 3 sets)
(pM) (ug Pi/mg prtn./l5 min) (%) (t-test)
0.01 17.5** 74.8 stim. p - 0.01
control 10.10
0.01 15.90 59.8 stim. p«0.01
control 10.10
0.08 10.88 27.2 stim. p < 0.05
control 8.55
0.08 11.13 33.8 stim. p < 0.05
control 8.27








100.0 15.44 46.8 stim. p <  0.05
control 10.66
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Table 6. Effects of STX on rat liver mitochondrial ATPases 
activities. 1 .0 - 1.5 mg mitochondrial protein, JO C, 0.25 M sucrose, 
JO mM KC1, 2 mM MgClg, 5 mM ATP, 5° mM Tris-HCl, pH 7.5, 1.0 ml final 
volume. Averages of J sets per experiment.
Saxitoxin ATPases Activities Effect Significance
(averages of J sets/exp)
(pM) (jig Pi/ mg prtn./ 15 rain.) (%) (t-test)





















0 .1 0 11.66
10.22
14.10 Stim. p<0 .10
0.01 18.64
17.79
4.78 Stim. p>0 .20
8 .1 0 17.47
16.54
5 .65 Stim. p>0 .10
* Insufficient number of assays to evaluate statistically
Table 7 shows the effects of SIX, TTX, and arcaine (an 
alkyl guanidine) on rat liver mitochondrial ATPases in the presence 
of 0.1 $ bovine serum albumin. Relatively low amounts of STX and TTX 
enhance the ATPases activities, a finding which is also demonstrated
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for much higher amounts of arcaine, a non-toxic alkyl guanidine.
As mentioned earlier, stimulation of latent ATPase activity is 
indicative of mitochondrial membrane damage. This observation 
is consistent with the report by Covell and Whedon (190) of 
pathologic damage to kidney convoluted tubule mitochondria caused 
by STX. Smilar findings for TTX have not been reported (2).
TTX, however, has been reported to produce a transient hyperglycemic 
response in animals and man (88). Furthermore, TTX appears to 
potentiate the action of insulin (89), The hypoglycemic reaction 
is similar to the response produced by the antidiabetogenic 
guanidine-containing drugs (183, 18*0, which are believed to exert 
their systemic actions as a result of inhibition of mitochondrial 
oxidative phosphorylation. It is reasoned that this inhibition 
of oxidative metabolism would be compensated for by an increase in 
glycolysis, thus causing hypoglycemia. In addition, Marumo et al. 
(79) have recently demonstrated an inhibitory action of TTX on rat 
liver mitochondrial oxidative phosphorylation.
The actions of the toxins on mitochondria swelling and 
ATPases activities is consistent with reports of mitochondria 
pathology and hypoglycemia. Mitochondrial membrane function dis­
ruption would result in enhanced latent ATPase activity, which would, 
in effect, reduce the energy (as ATP) producing capacity of the 
mitochondria. This inhibition of energy production could result 
in compensatory increased glucose utilization, thus causing 
hypoglycemia.
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It is extremely unlikely, however, that the actions of the 
toxins on mitochondria are responsible for neuromuscular conduction 
blockade. This statement is based on the observations that 
(i) internally-perfused squid giant axons, devoid of 99 % of their 
axoplasm, are capable of conducting "normal* action potentials for 
several hours (48), indicating that mitochondria sure not required 
for axonal conduction; such preparations are readily blocked by 
TTX (48, 50, 52)1 (ii) the blocking sites for TTX are located on 
the external surface of nerve membranes; application of the toxin 
to the internal surface of perfused axons is ineffectual in achieving 
conduction block (191, 192).
These findings strongly militate against the direct involve­
ment of mitochondria in the action potential generating mechanism 
and hence, against the possibility that STX and TTX exert their 
primary blocking actions by influencing mitochondria activity. It 
seems likely, moreover, that the secondary systemic actions of the 
toxins, namely mitochondria pathology and hypoglycemia, are a result 
of the direct action of the toxins on mitochondria. The toxins 
appear to act on the mitochondrial membranes, disrupting them 
functionally, as measured by alterations of the swelling and ATPases 
activities of isolated mitochondria.
2. Effects of Saxitoxin, Tetrodotoxln. and Related 
Compounds on Brain Microsomal Adenosine Triphosphatases 
It is widely held that the electrochemical potential that 
exists across nerve and muscle cell membranes is maintained by a
5 7
"sodlura pump*, or the (Na^-K*)-activated ATPase (159, 195, 194), 
a membrane-bound enzyme which can be isolated from microsomes 
(159, 194). The generation of action potentials can be imagined 
to result from a temporary •shutting down* of the dodium pump, 
during which time sodium and potassium ions are allowed to flow 
down their respective electrochemical gradients. STX and TTX 
appear to prevent the flow of sodium ions down their gradient (35).
It seemed likely, therefore, that the molecular mechanism of the 
toxins' actions could be explained on the basis of precluding 
sodium pump shut-down. Since the activity of the (Na+-K+)- 
activated ATPase can be inhibited by ouabain (193)» & method of 
testing the above hypothesis of the toxins' actions seemed readily 
at hand. If the theory was correct, the toxins should prevent 
ouabain inhibition of the ATPase activity. The toxins might also 
increase the activity of this enzyme.
A preliminary 3tudy was performed to determine the effects 
of STX on ATPases activities present in whole brain homogenates.
Due to the crude nature of the preparation, no dramatic effects 
were anticipated and none were found for the effects of 'MX and 
STX (1.0 pM). A similar report for TTX has recently appeared in 
the literature (77).
Bat brain microsomes were prepared and the effects of the 
toxins in the presence and in the absence of ouabain on their 
ATPases activities were examined. As can be seen in Table 8, TTX 
(7.8 pM) was ineffectual under these conditions, thus seeming to 
rule out the possibility that TTX exerts its action via the
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Table 8. Effects of STX and TTX in the presence and in the absence 
of ouabain (10“%) on the activity of rat brain microsomal ATPases. 
100 mM NaCl, JO mM KC1, 100 mM Tris-HCl. pH 7.4, 4 mM MgCl2, J mM 
ATP, 50 - 200 pg microsomal protein, 57 C, 1.0 ml final volume.
Agent Tested ATPases Activities 
(averages of 5 sets)





1.0 pM SIX e.$o 26.7 Inhib. p<0.001
control 11.50
8 .0 pM STX 16.20
control 18.90 14.2 Inhib. P<0.01
ouabain 5 .10 28 .0 Inhib. peO.05
control 7.50
ouabain plus
0 .8 pM STX 4.10 42.8 Inhib. p<0 .0 5
(Inhibitory effect of STX alone) 14.8 Inhib. p<0 .0 2
7.8 pM TTX 21.02 0 .6 Stim. no signif.
control 20.90 diff.
ouabain 6.70 50.1 Inhib. p<0 .05
control 9.45
ouabain plus
7.8 pM TTX 6 .10 56 .8 Inhib. p<0 .0 5
(Inhibitory effect of TTX alone) 6.7 Inhib. no signif.
diff.
ouabain 5.55 25 .6 Inhib. psO.05
control 4.65
51 pM TTX 4.55 6.2 Inhib. no signif.
diff.
(Na+-K*)-activated ATPase. SIX, on the other hand, inhibits the 
enzyme activity; however, it appears to be acting not on the ouabain- 
sensitive ATPase, but on another enzyme present in the microsomes since 
the inhibitory effects of ouabain and STX are additive. Evidence to be 
presented later in this manuscript strongly implies that STX is
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inhibiting a non-(Na+-K+)-activated ATPase present in brain microsomes.
It seems clear that neither TTX nor STX are able to overcome the inhibi­
tory effects of ouabain on the sodium pump enzyme. This seems to rule 
out the possibility that the toxins act by precluding pump shut-down.
In an attempt to delineate which microsomal ATPase was being acted 
upon by STX, a study of a purified (Na4-K4)-activated brain microsomal 
ATPase was undertaken (see METHODS AND MATERIALS). On the basis of 
ouabain inhibition, this enzyme was estimated to be 60 % pure. STX 
(0.1 - 50.0 pM) had no effect on the activity of this enzyme. This lent 
further credence to the suspicion that the sodium pump enzyme is not 
involved in the conduction blocking mechanism of STX.
Rat brain microsomes incubated in the absence of added sodium and 
potassium, but in the presence of magnesium ions exhibit Mg44-activated 
ATPase activity (165). In Figure 15 can be i*3en the effects of 2 pM STX 
on the activities of the rat brain microsomal (Na^ -K4)-activated ATPase 
and on the Mg -activated ATPase, separated by differential assay. The 
apparent inhibitory effect of SIX on the (Na4-K4)-activated ATPase is 
most likely due to inhibition of the Mg++-activated ATPase. At higher 
substrate concentrations, the effect of STX on the Mg44-activated ATPase 
tends toward stimulation, rather than inhibition.
Nakamaru and Konishi (166-168) have described a microsomal ATPase 
that is activated by magnesium and trace amounts of calcium. This 
enzyme may or may not be distinct from the Mg+4-activated ATPase stud . 
above. The effect of STX, at various concentrations of ATP, on this 
enzyme's activity are shown in Figure 16. A modest inhibition (11 %) 

















Fig. 15. Effects of STX on rat brain microsomal ATPases activities 
at various ATP concentrations, (a) 100 mM NaCI, 30 mM KC1, 3 mM MgCl,,, 
(b) 100 mM NaCI, 30 mM KC1, 3 mM MgCl , 2 pM STX, (c) 3 mM MgCl ,
2 pM STX, (d) 3 mM MgCl?. 0.25 mg microsomal protein, 100 mM 
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Fig. 16. Effects of STX on rat brain microsomal (Mg++ + Ca**)- 
activated ATPase activity at various ATP concentrations, (a) control,
(b) 1 pM STX. 0.5 mg microsomal protein, 50 mM Tris-HCl, pH 0.02 %
digitonin, 5 mM MgCl?, 0.03 mM CaCl?, 0.125 mM ouabain, 1 ml, 10 minutes, 
37 C.
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A Lineweaver-Burk plot of this experiment (Fig. 17) suggests a non­
competitive form of inhibition for SfX (the s are not changed,
whereas the V 's differ by 11 f»). 
max
The foregoing experiments indicated that STX, although not TIX, 
could inhibit a non-(Na+-K+)-activated, ouabain-insensitive ATPase 
present in rat brain microsoraes. A Mg++-, or a (Mg++-Ca++)-activated 
ATPase appeared to be the likely target of STX's action. The function 
of this enzyme in brain tissue is not known, thus the effect of STX 
on this enzyme's activity provides no immediate explanation for the 
neuromuscular conduction blocking action of the toxin.
My attention was then drawn to reports in the literature of the 
existence of a "contractile protein" in neuronal tissue with enzymatic 
activities resembling muscle actomyosinj an ATPase activated by either 
magnesium or calcium (119, 120). It seemed possible that the brain 
microsomal enzymes that I had found to be sensitive to STX could be 
actomyosin-like ATPases. The existence of similar enzymes in nerve and 
skeletal muscles could provide an explanation for the unique sensitivity 
of these cells to STX and TTX, provided that these enzymes were 
sensitive to the toxins. The reported effects of SIX on sea urchin 
egg cleavage (41, 42) could also be related to an action on contractile 
proteins, since it is well established that the mitotic spindle 
apparatus, consists of actin-like proteins (124). The inhibitory action 
of TTX on blood coagulation (90, 91) might be related to an effect on 
an actomyosin-like protein. Blood platelet membranes contain throm- 
bosthenin (115—116), an actomyosin-like ATPase that is insensitive to 
ouabain (115). This protein plays a vital role in platelet coagulation, 






Fig. 17. Lineweaver-Burk plot of the data shown in Fig. 16. (a) STX,
0,5 control. K - 0.227 M. V ( , - 2.185, VM x  (oontrol) - 2.1*50
pmoles Pi/ mg prtn/ hr.
64
Consequently, the efforts of this project became focused on 
establishing the existence of contractile proteins in neuronal tissues, 
in addition to demonstrating the effects, if any, of the toxins on the 
activities of these proteins.
5. The Isolation of Neuronal "Contractile Proteins1 
and Their Possible Identity with Other Contractile Proteins 
In the foregoing paragraphs a rationale for demonstrating the 
presence of actomyosin-like proteins in neuronal tissues was presented. 
The possibility that the microsomal ATPases studied earlier might be 
"contractile proteins" was also discussed. In this section, evidence 
is provided that strongly indicates the existence of actomyosin-like 
proteins in crayfish ventral nerve cords, and in brains of rat, rabbit, 
lamb, and bovine origin.
Bowler and Duncan (119) have previously reported the isolation 
of a contractile protein from crayfish ventral nerve cords. My studies 
substantiate their findings. The unique property of contractile 
proteins is their tendency to undergo superprecipitation or syneresis 
in response to ATP (102). Figure 55 illustrates the superprecipitation 
of crayfish ventral nerve cord contractile protein by ATP. As discussed 
later, this protein also exhibited ATPase activity.
The paucity of material available from crayfish ventral nerve 
cords necessitated employment of a different source of neuronal tissue 
for definitive biochemical studies.
Preliminary studies of the protein extractable from rat brains 
by the Szent-Gyorgyi actomyosin isolation method (102) also indicated 
the presence of an actomyosin-like protein in this tissue, as has been 
reported by Puszkln et al. (120).
If the brain protein was similar to actomyosin, it should be 
possible to dissociate free myosin from the actin-myosin complex by 
treating the protein with ATP, followed by gel filtration on columns 
equilibrated and eluted with a buffered ATP solution (109). Actomyosin 
obtained from brains by the Szent-Gyorgyi method was further purified 
by passage through a Sepharose 4£ column (Fig. 18). 'The major peak 
was treated with ATP and loaded onto a second Sepharose 4B, or a 
Sephadex G-200, cdlumn, eluted and equilibrated with a buffered ATP 
solution. The appearance of multiple fractions following this treatment 
are shown in Figure 19. The ATPase activities of the four major peaks, 
and their possible identities are presented in Table 9. The first peak, 
on the basis of its elution behavior, may correspond to undissociated 
actomyosin-like protein. It has the highest ATPase activity, consistent 
with the knowledge that actomyosin ATPase activity is greater than 
myosin ATPase activity (195). Peaks II and III have similar ATPase 
activities and only slightly different molecular sizes. These peaks 
probably represent different aggregation states of free myosin-like 
protein. Peak IV is devoid of ATPase activity and most likely represents 
free actin-like protein. The high 260 mp absorbance of the fractions 
was a constant source of puzzlement, although it is now suspected that 
part of it can be accounted for by the presence of HNA, and part is 
most likely attributable to tightly bound adenosine nucleotides. The 
260 mp absorbance could not be reduced by either gel filtration or 
exhaustive dialysis. As seen in Figure 20, a small portion of the 
260 rap absorbing material could be removed by treating the myosin-like 
protein with pancreatic ribonuclease, indicating that a small pertion 
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Fig. 18. Elution profiles of brain actomyosin-like proteins, 
prepared by the Szent-Gyorgyi method, from Sepharose 4B columns, 
(a) rat brain actomyosin (90 mg), 1.7 x 25 cm column, 60 ml/ hr, 
eluted with 0.6 M KC1, 50 mM Tris-HCl, pH 7.2; (b) rabbit brain 
actomyosin (186 mg), 1.7 x 35 cm column, 50 ml/ hr, eluted with 







Fraction No. (15 ml/ fx)
Fig. 19. Fractionation of lamb brain actomyosin-like protein 
dissociated by ATP, eluted from Sepharose 4B column (2.5 x 60 cm) 










Fraction No. (5 ml/ fx)
Fig. 20. Gel-filtration of lamb brain myosin on columns of 
Sephadex G-200 (1,3 x 15 cm), eluted with 0.02 M Na^ PgO-, pH 
8.2. (a) before and (b) after treating 8 mg brain myosin protein
with 650 pg pancreatic ribonuclease (Worthington), for 30 minutes 
at 37° C.
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Table 9. ATPase activities and possible identities of ATP- 
dissociated and Sepharose 4B fractionated lamb brain actomyosin- 
like protein fractions.
Peak ATPase activity Identity
(Fig. 19) (praoles Pi/mg prtn./hr.) (possible)
I O.708 undissociated "actomyosin*
II 0.426 free "myosin* aggregate
III O.388 free "myosin* aggregate
TV 0.000 free "actin"
Further purification of myosin-like brain proteins, obtained 
either by dissociation from actomyosin-like proteins or by the direct 
myosin extraction procedure (described in METHODS AND MATERIAIS) was 
performed by gradient elution from DEAE-columns.
Figure 21 shows the fractionation of rat muscle myosin on DEAE- 
Cellulose, eluted with the step-gradient system described by Baril 
et al. (171) for chick embryo muscle. The elution profile is 
qualitatively identical with that noted by Baril et al., only minor 
quantitative differences being observed. Table 10 presents the findings 
of Baril et al. for chick embryo muscle myosin fractionated on columns 
of DEAE. Fraction IV ("pure* myosin) of rat muscle myosin was pooled, 
concentrated by dialysis against polyethylene glycoljdesalted on a 
Sephadex G-200 column, and rechromatographed on DEAE-Sephadex, -using 
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Fig. 21. Rat muscle myosin fractionated on a DEAE-Cellulose column 
(2 x 20 cm), eluted according to Baril et al. (I7l)» with 50 ml buffer 
changes. 232 mg protein.
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Table 10. Composition of fractions recovered from HEAE! columns, 
used for myosin fractionation, eluted with the system described 
by Baril et al. (171).




I >1.0 none non-acidic proteins
II >1.0 myosin-HNA complex
III >1.0 ♦+ myosin-HNA complex
IV >1.0 ♦ pure myosin
V <1.0 none ribonucleoprotein
The major peak of the resultant fractionation (Peak II in Fig. 22) 
was taken as pure myosin and analyzed by polyacrylamide discontinuous 
gel electrophoresis. The high molecular weight of myosin apparently 
prevented the protein from penetrating the 7 % gel. Only traces of 
proteins were observed to have entered the gel, whereas a large, deeply 
stained ring of protein remained at the origin. It was estimated that 
the myosin prepared in this manner was 80 - 90 % pure.
The same fractionation procedures used for muscle were also 
used for brain tissue. Fractionation of a bovine brain myosin pre­
paration on a HEM-Sephadex column, using the step-elution system, is 
shown in Figure 2J. Peak IV was subsequently rechromatographed on a 
second BEAE-Sephadex column and eluted with the step-gradient elution 
system. As can be seen in Figure 24, the preparation now was chroma- 
tographically pure. Polyacrylamide disc, gel electrophoresis showed 
the absence of contaminating proteins (i.e., those capable of entering 
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Fig. 22. Rechromatography of rat muscle myosin peak IV on DEAE-Sephadex A50 (2.5 x 25 cm) 











Fraction No. (6 ml/ fx)
Fig. 23. Fractionation of bovine brain myosin on a DEAE-Sephadex A50 
column (2.5 x 30 cm) with the elution system of Baril et ad. (171); 
200 ml buffer changes, ^,1 g protein.
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Fig. 24. Rechromatography of bovine myosin peak IV on a DEAE-Sephadex 
A50 column (1.3 x 55 cm) eluted according to Baril et al. (l?l) with 50 
ml buffer changes. 450 mg protein.
Similar fractionations of myosin-like proteins from rabbit 
and lamb brains axe shown in Figures 25 and 26.
Actomyosin is characterized by a relatively high content of 
acidic amino acid residues and of cysteine. The chromatographic 
behavior of the contractile proteins on DEAE columns presented in 
this study are consistent with the proteins being acidic. The high 
cysteine content of actomyosin is responsible for the sensitivity 
of the ATPase activity to sulfhydryl blocking agents such as the 
mercurials (105), for example, para-chloromercuribenzoate (PCMB).
The inhibition of rat brain actomyosin ATPase activity by PCMB is 
shown in Figure lending further support to the contention that 
the brain ATPases being studied resemble muscle actomyosin.
Another characteristic of actomyosin ATPase activity is the 
influence of ionic strength on the divalent cation requirement for 
activation (105). At low ionic strength (0.1 M KOI), the enzyme is 
activated by magnesium ions, whereas, at 0.6 M KC1, calcium is the 
required cation. These findings have been verified for rat brain 
actomyosin, as shown in Figure 27.
Although actomyosin can be activated by either magnesium or 
calcium, myosin can be activated only by calcium ions (105). This 
characteristic was also found to be true for the brain myosins 
examined in these studies.
Brain actomyosin preparations were later found to be activated 
at 0.6 M KC1 by magnesium as well as by calcium ions (Fig. 28). 
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Fig. 25. Fractionation of rabbit brain myosin on a DEAE-Sephadex A50 
column (1.3 x 15 cm) eluted according to Baril et al. (171) with 50 ml 
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Fig. 26. Fractionation of lamb brain myosin on a DEAE-Sephadex A50 
column (1.7 x 20 cm) eluted according to Baril et al. (171) with 50 
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Fig. 27. Effects of ionic strength on divalent cation requirement 
for ATPase activity of rat brain actomyosin. (a) 0.6 M KC1, 3 mM
CaCl?, (b) 0.1 M KC1, 3 mM MgCl-. 2 mg protein, 50 mM imidazole, 
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Fig. 28. Effects of (a) calcium and (b) magnesium on ATPase activity 
of rat brain actomyosin. 0.6 M KC1, 10 mM histidine, pH 6.5, 1 mM 
ATP, 1.0 ml, 37 G, 30 minutes, 0.4 mg protein.
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Another characteristic feature of the ATPase activity of 
actomyosin and myosin is the effect of pH on the enzymatic activity. 
Figure 29 shows a pH - ATPase activity profile for rat muscle myosin. 
The activity peaks at pH 6 .5 and at 8 .0 . A similar profile was 
discovered for rat "brain actomyosin ATPase and is also shown in 
Figure 29.
Substrate-inhibition of myosin ATPase activity has been 
previously noted (102). As seen in Figure JO, brain myosin ATPase 
activity also is inhibited by high substrate concentrations.
Brain actomyosin preparations, like muscle actomyosin, were 
very difficult to solubilize, even in 0.6 M KC1. Attempts to improve 
the solubility of brain actomyosin with 2 % sodium deoxycholate v/ere 
unsuccessful. The proteins were, however, readily soluble in 
0 .0 2 M Na4P207, pH 8 .2, a finding also true for muscle actomyosin.
Once solubilized, the pyrophosphate, which inhibits ATPase activity, 
was removed by replacement dialysis against 0 .6 M KC1.
Baril et al. (171) stated that 2-aminoethylisothiouronium 
(AEI) enhanced the activity of muscle myosin ATPase. No explanation 
for this effect or the magnitude of the stimulation was indicated.
It seemed appropriate, therefore, to examine the effects of this 
compound on rat muscle myosin ATPase activity as well as on the brain 
contractile proteins ATPase activities.
AET was found to be an extremely potent stimulator of muscle 
myosin ATPase activity; a 1.2 fold stimulation being observed with as 
little as 0.1 jiM AET, while 0 .5 mM AET produced a J.6 fold stimulation 










Fig. 29. Effects of pH on ATPase activities of (a) rat muscle 
myosin and (b) rat brain actomyosin. 0.6 M KC1, 3 mM CaCl_,
1 mM ATP, 10 mM buffer (histidine, pH 6 - 6.5* Tris-HGl, pH 7 - 
8.5; lysine, pg 9 - 9*5)» 225 VS muscle myosin, 378 jig brain











Pig. 30. Effects of substrate concentration on ATPase activity of 
lamb brain myosin. 225 Pg protein, 0.6 M KG1, 3 mM GaCl^ * 50 mM 
imidazole, pH 6.5, 37 C» 1*0 ml, 5 minutes.
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less stimulatory, and at 4.0 mM AET, enzyme activity had returned 
to base-line levels, as seen in Figure 31.
The action of AET on the ATPase activity of rat brain actomyosin 
was less dramatic, although a 1.5 fold stimulation was observed with 
1.0 mM AET (Fig. 32)* As with muscle myosin ATPase activity, higher 
concentrations of AET were less effective in stimulating brain acto­
myosin ATPase activity. The differences in the effects of AET on 
muscle myosin and brain actomyosin ATPase activity might be related 
to a differential effect of AET on myosin as opposed to its effect on 
actomyosin. It is also possible that the differences are attributable 
to pH differences (muscle myosin assayed at pH 8.0, and brain acto­
myosin assayed at pH 6.5 ) and/or to differences in activating cations 
(calcium for muscle myosin, and magnesium for brain actomyosin). The 
similarities of the AET effects seemed to be sufficient evidence 
further favoring the possible identity of brain contractile proteins 
with those present in muscle.
The foregoing experiments provide considerable evidence for the 
contention that neuronal tissues contain contractile proteins that are 
similar, if not identical to the actomyosin present in skeletal muscle. 
It is hypothesized that the neuronal contractile proteins are located 
in the cell membranes, where they play an essential role in the 
excitation process. The requirement for membrane subunit conforma­
tional changes in Tasaki's physicochemical theory of nerve excitation 






Fig. 31. Effects of 2-aminoethylisothiouronium bromide (AET) on 
rat muscle myosin ATPase activity. 3^ 5 PS protein, 0.6 M KC1,
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Fig. 32. Effects of AET on ATPase activity of rat brain actomyosin. 
378 jig protein, 0,6 M KG1, 10 mM imidazole, pH 6.5, 1 mM ATP, 2 mM 
MgClg, 1.0 ml, 37 C, 15 minutes.
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4. The Effects of Saxitoxin, Tetrodotoxin, and Related 
Compounds on Contractile Proteins 
The preceding experiments have provided considerable evidence 
for the existence of neuronal contractile proteins that are similar, 
if not identical to actomyosin. It was hypothesized that these proteins 
might be membrane-bound, where, it is further theorized, they might play 
an essential role in the molecular mechanisms of nerve excitation. 
Neuronal membrane contractile proteins could well accommodate the 
requirement for a conformationally dynamic membrane in Tasaki's theory 
(151) of nerve excitation. Accordingly, it seemed plausible that inter­
actions of STX and TTX with these neuronal contractile proteins might 
form the basis for neuromuscular conduction block.
The inhibitory effects of SEX on crayfish ventral nerve cord 
contractile protein superprecipitation and on the ATPase activity of 
this protein are shown in Figure 53 and in Table 11. ITX (0.012 pM) 
did not affect either property of crayfish ventral nerve cord con­
tractile protein. At that time, higher concentrations of TIX were not 
available, thus it cannot be said with certainty that TEX does not 
influence the activity of this enzyme. As can be seen from Table 11,
5.5 pM STX produced nearly a 5° % inhibition of the ATPase activity 
and higher amounts of SIX (i.e., 26.6 pM) inhibited the superprecipi­
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fig* 33. Effect of STX on superprecipitation of crayfish ventral nerve 
cord contractile protein, (a) control, (b) 27 jiM STX. 1.5 mg protein, 
30 mM Tris-HGl, pH 7.2, 6 mM MgCl , 2b G, 2.5 ml. * indicates addition 
of 0.8 mM ATP. ^
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Table 11. Effects of STX on superprecipitation and on the ATPase 
activity of crayfish ventral nerve cord contractile protein. 
Conditions of the superprecipitation study are given in Figure 53. 
The ATPase activity was determined in the presence of JO mM Tris- 
HC1, pH 7.2, 4 mM MgC^, 2 mM ATP, with O.75 - 1.0 mg protein, at 
25°C, 15 minutes, 1 .0 ml final total volume.
Saxitoxin ATPase Activity Effect
(yM) (pg Pi/mg prtn./hr) (%)
3.5 4.96 47.6 Inhib.
control 9 .48
5.5 5.00 47.5 Inhib.
control 9.48
26.6 Superprecipitation 20.0 Inhib.
(see Fig. 33)
Similar experiments were performed using rat brain actomyosin.
Figure j4 shows the effects of various concentrations of ATP and the
effect of STX on the ATPase activity of rat brain actomyosin. For
comparative purposes, PCMB inhibition of this enzyme's activity is
also illustrated. A Lineweaver-Burk plot of the data in Figure j4
suggests a non-competitive form of inhibition for SIX, since both
K-'s are 0.71 mM, whereas the V 's differ by nearly 15 $ (Fig. 35). 
w max
Note that at high substrate concentrations, the inhibitory effect of 
STX is reversed, a finding seen earlier in studies of the microsomal 
Mg44,-activated ATPase. In order to better elucidate this anomalous 
effect, a kinetic study was performed, employing the coupled enzyme 
system described earlier. Table 12 summarizes the effects of STX on 
the ATPase activity of rat brain actomyosin as a function of time and 







Fig. 34. Effects of STX and PCMB on ATPase activity of rat brain 
actomyosin at various ATP concentrations, (a) control, (b) 1 jiM 
STX, (c) 3 mM PCMB. 0.1 M KC1, 10 mM imidazole, pH 6.8, 3 mM MgClg, 
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Fig* 35* Lineweaver-Burk plot of data shown in Fig. Jk. (a) 1 uM 
STX, (b) control. K - 0.71 mM. V - 1.4-0, V , . . .
1.70 pg Pi/ mg prtn/ Rr. max (STX) m * (control)
t
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STX are greatest during the earliest phases of the reactions, "becoming 
less marked, and in some instances stimulatory, in the terminal stages 
of the reactions. The inhibitory effects of STX were greatest at
Table 12. Reaction time-, substrate concentration-dependence of 
inhibitory action of STX (7.9 pM) on rat brain actomyosin ATPase 
activity determined by the coupled enzyme procedure. 
pH 6.8, 2 - 4 mg protein, 57°C.
ATP Cone, Effect of STX on the ATPase activity at the 
indicated reaction times (seconds)
(mM) 125 250 575 500 625
0.75 +14.0$ ♦55.30 +5 6.6$ ♦52.60 +47.0$
1.88 -58.0# -11.50 +20.8$ ♦51M +49.50
5.76 —66.2# -66. 5$ -5^.00 -46.0$ -40.0$
optimal substrate concentrations (i.e., 5.76 mM ATP), while at low levels 
of ATP (0.75 “M)* the toxin stimulated the enzymatic activity. Inter­
mediate toxin effects were seen at intermediate substrate concentrations. 
Although no clear explanation for these observations is immediately 
apparent, these effects might be due to combined effects of ATP and STX 
on different conformational states of the enzyme. That the enzymatic 
activity exhibits a lag phase in all cases in the presence of the toxin 
could be indicative of an allosteric toxin-enzyme interaction. Incidentally, 
STX and TTX (0-600 pM) do not inhibit the ATEregenerating or the NATH 
oxidation reactions employed in the coupled enzyme assay.
Although an effect of TTX on microsomal ATPases was not observed 
earlier, the toxin clearly influences the behavior of rat brain actomyosin
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ATPase activity. Like STX, the effects of TTX on this enzyme's activity 
shows an anomalous reaction time-, substrate concentration-dependence, 
as shown in Table 15. The inhibitory effect of TTX is greater at higher 
substrate levels and, again, a definite lag phrase of the ATPase activity 
is seen in the presence of the toxin. This may indicate that the toxin 
is binding to a site, or sites, on the enzyme, and slowing the reaction 
rate; however, the substrate eventually overcomes the inhibitory influence 
of TTX on the enzyme, perhaps by altering the enzyme's conformation.
Table 15. Reaction time-, substrate concentration-dependence of 
inhibitory action of TTX (60.4 pM) on rat brain actomyosin ATPase 
activity determined by the coupled enzyme procedure. pH 6.8, 2 - 4 mg 
protein, 57°C.
ATP Cone. Effect of TTX on the ATPase activity at the indicated 
reaction times (seconds)
(mM) 125 250 575 500 625 750
5.76 -47.4$ -52.6$ -25.2$ -6.0$ +21.6$ +21.0$
7.52 -100.0$ -90.0$ -56.5$- -41.0$ -29.4$ -15.6$
Local anesthetics such as procaine are the only known pharmacological 
agents that at all resemble TTX and STX in their blocking actions. The local 
anesthetics, however, inhibit both early and late ionic conductance phases 
of the action potential (192). As seen in Table 14, procaine also inhibits 
the ATPase activity of rat brain actomyosin. Unlike the inhibition observed 
for STX and TTX, however, procaine inhibition is greater at lower substrate 
levels and is less variable with time. Procaine inhibition also shows a 
lag phase for the ATPase activity.
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The effects of d-amphetamine (1.0 mM), a sympathomimetic amine, 
on the ATPase activity of rat brain actomyosin as a function of time 
and substrate concentration are also given in Table 14. Amphetamine, 
a CNS stimulant, also stimulated the ATPase activity of rat brain acto­
myosin. At higher substrate levels, however, amphetamine was inhibitory. 
The stimulating effects of amphetamine, furthermore, tapered off as the 
reactions progressed.
Table 14. Effects of procaine (57 mM) and d-amphetamine (1.0 mM) on the 
ATPase activity of rat brain actomyosin at different reaction times and 
at different substrate concentrations. pH 6.8, 2 - 4 mg protein, 57 C.
ATP Cone. Effect of agent on the ATPase activity at the 
indicated reaction times (seconds).
(mM) 125 250 575 500 625 75O
0.75 -81 .375
(procaine)
-58.075 -51.275 -47.575 -41.0$ -41.8$
1.88 -50.C# 
(procaine)
-55.575 -51.675 -28.0$ -26.6$ -25.4$
1.60 *-55.07$ 
(amphetamine)
+28.67$ - 6.07$ -17.0$ -20.0$ -28.5$
2.40 +16.57$ 
(amphetamine)
-20.07$ -51.275 -55.575 -57.975 -42.5$
In contrast with the previously noted lack of TTX effect on crayfish 
ventral nerve cord contractile protein superprecipitation, TTX was found 
active in inhibiting rat brain actomyosin superprecipitation (Fig. 56).
This discrepancy is probably due to differences in toxin concentrations 
employed for the two studies (only 0.012 pM TTX as opposed to 60.4 pM). 











Pig. 36. Effects of TTX on superprecipitation of rat brain actomyosin 
by ATP, added at time zero, (a) control, (b) 60 uM TTX, 3*76 mM ATP, 
(c) 60 pM TTX, 7.5 mM ATP. 0.6 M KG1, 3 mM MgCl , 10 mM imidazole, 
pH 6.8, 1.0 mg protein, 2.5 ml, 37° C.
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was influenced by the reaction time, inhibition of superprecipitation 
was relatively constant throughout the time course of the reaction.
The inhibitory effect of TTX on superprecipitation, as on the ATPase 
activity, was greater at higher substrate levels. TTX (60.4 pM) 
inhibited the superprecipitation reaction 58 % in 'the presence of 
7.5 mM ATP, while at 5.7 mM ATP, the toxin produced a 5° % inhibition.
Procaine (57 mM) was also found to inhibit the superprecipitation 
reaction 5° in the presence of 7.5 mM ATP.
As previously cited, TTX inhibition of rat brain actomyosin 
ATPase activity varied directly with ATP concentration. Whereas 60 pM 
TTX achieved a 58 % inhibition of the enzymatic activity in the presence 
of 7.5 mM ATP, not even J00 pM TTX was found to inhibit the ATPase 
activity more than 20 % in the presence of only 1.0 mM ATP. The effects 
of varying TTX concentrations on the ATPase activity are shown in 
Figure 57.
It is interesting to recall that aminoetbylisothiouronium (ABP), 
a compound that shares some of the structural features common to SIX 
and TTX (Fig. 58), was found to be a potent stimulator of rat muscle





















Fig* 37* Effects of TTX on ATPase activity of rat brain actomyosin. 
378 pg protein, 0.6 M KC1, 10 mM histidine, pH 6.5, 1 mM CaCl_, 1 mM 
ATP, 1.0 ml, 37 C, 15 minutes.
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myosin and. rat Drain actomyosin ATPase activities. This may indicate 
that the toxins and. AM' are interacting with a conformation-determining 
site in the enzyme. Although the ATPase activity of brain actomyosin 
in the simultaneous presence of toxin and AET was not investigated, such 
a study of muscle myosin ATPase activity did indicate that equimolar 
concentrations of AET could nullify the inhibitory effefct of STX on 
the ATPase activity. Increasing the STX i AET ratio beyond 2 t 1, 
however, produced variable results.
The preceding experiments provide information indicating that 
STX and TTX, dependent on substrate concentration, exert inhibitory 
effects on the ATPase and superprecipitation activities of rat muscle 
actomyosin, crayfish ventral nerve cord contractile protein, and rat 
brain actomyosin. A study of the effects of the toxins on isolated 
myosin, prepared from muscle and brain, was undertaken in an attempt 
to pinpoint the site or sites of action of the toxins more specifically. 
Were the toxins inhibiting the myosin activities directly or were they 
doing so only indirectly through interaction with the actin portion of 
the contractile proteins?
The effects of STX on rat muscle myosin ATPase activity as a 
function of various parameters(enzyme concentration, substrate, and 
calcium concentrations) are summarized in Table 15. A salient feature 
of this experiment was the finding that SIX inhibition varied as an 
inverse function of calcium concentration, being greatest at lowest 
levels of calcium. This could mean that the toxin and Ca++ are competing 
for similar sites on the enzyme. In view of the role proposed by 
Tasaki (1J1) for Ca++ in regulating the conformational states of 
excitable membrane subunits, the possibility of a toxin - Ca++
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competition for sites on a contractile protein becomes quite 
meaningful.
Table 15. Effects of STX (155 pM) on rat muscle myosin ATPase activity. 
0.6 M KC1, 10 mM buffer (histidine, pH 6 - 7; Tris-HCl, pH 7 - 9; lysine, 
pH 9 - 9.5)» 57°C, 15 minutes, 1.0 ml final volume.
Enzyme Cone. Parameters Inhibition
(pg prtn/ral) (%)
49.0 pH 6 .8 (5 mil Ca++, 5 mM ATP) 61.0
167.0 pH 8 .5 (■ " ■ ■ ■ ■ ) 68 .0
225 .0 0.1 mM Ca*+(pH 6.8, 0 .5 mM ATP) 44.5
225 .0 0 .2 5 ■ • ■ • • « ) 55#7
225.0 0 .5 0 * • (■ ■ " » " ) 18.2
225 .0 1.00 ■ ■  (■ " " " * ) 16.1
225 .0 5 .00 » ■ (■ ■ * ■ ■ ) 7.6
As can be seen in Figure 59, the inhibitory action of SIX on rat 
muscle myosin ATPase activity is little influenced by pH differences, a 
finding that is contrary to the effectiveness of TTX in blocking con­
duction along nerves (71). SIX carries two positive charges at pH values 
below 8.5 (15), while above pH 8.5, the toxin is only singly charged.
TTX, on the other hand, is only monobasic in the lower range of the pH 
scale (28), while at alkaline pH values, TTX exists as an uncharged 
zwitterion. These findings may indicate that the biological effectiveness 














Fig. 39* Effect of STX on ATPase activity of rat muscle myosin 
at different pH values, (a) control, (b) 66 pM STX. 0.6 M KOI,
10 mM buffer (histidine, pH 6 - 6.5; Tris-HCl, pH 6.5 - 9i lysine, 
pH 9 - 9*5)» 0.1 mM CaCl2, 0.5 mM ATP, 225 pg protein, 37 C, 5 
minutes.
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A kinetic analysis of the effects of STX on rat muscle myosin 
ATPase activity was undertaken, employing the coupled enzyme method 
described previously. Straight lines were fitted to the reaction 
plots, in order to determine linear rates of absorbance changes. From 
these curves the rates of NAOH oxidation were calculated and interpreted 
as specific activities of the ATPase being studied.
Table 16 summarizes kinetic studies of the effects of STX on 
rat muscle rayo3in ATPase activity. The data from one of these experi­
ments is plotted as specific ATPase activity versus reaction time in 
Figure AO, from which it is evident that (i) the toxin causes a con­
siderable lag phase of the reaction and (ii) the toxin actually alters 
the reaction rate. Toxin-induced lag phases were noted earlier in
studies of rat brain actomyosin ATPase activities. lag phases and 
%
altered reaction rates were consistently found in the present studies, 
further supporting the possibility that the toxin is binding to the 
enzyme and altering its conformation to a less active state. The 
disappearance of the lag phase as the reactions progressed may indicate 
an additional effect of ATP on the enzyme's conformation, which 
partially overcomes the inhibitory influence of STX. The inhibition 
seems to be a direct function of the S'TX concentration.
A log dA_. versus reaction time plot of the data shown in JAO
Figure 40 was constructed and is shown in Figure 41. The toxin- 
induced lag phase is clearly apparent in this plot. In addition, the 
differences in reaction rates of control and toxin-inhibited reactions 
are more readily distinguished. This plot seems to indicate that the 
control reaction is greater than first order, whereas the inhibited
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Table 16. Effects of STX on rat muscle myosin ATPase kinetics determined by 
the coupled enzyme method. 0.06 M KC1, 10 mM histidine, pH 6 .8, 5 mM MgCl , 



















5.5 184.5 0 .102 5.52 9.2 2.28 4.12
control 0 .112 5 .8 6 2.19
55.0 184.5 0.124 6.48 25.6 2.15 22.20
control 0 .162 8.47 1.76
26 .5 184.5 0 .116 6 .0 5 52.7 2.08 14.50
control 0.172 8.99 1.82
106.0 184.5 0.112 5.85 51.7 2.19 21.00
control 0.164 8 .5 6 1.81
106.0 125.0 0.048 5.7 6 51.5 5.04 14.50
control 0 .070 5.47 2.66
106.0 61 .5 0 .018 2.81 21.8 4.02 6.55
control 0 .025 5.59 5.78
212.0 125.0 O.O58 2.98 40.2 5.27 18.40
control 0.064 5.05 2.76
reaction displays a lag phase, followed by first order, and finally zero 
order kinetics. If first order kinetics are assumed, however, the rate 
constants, K, for the reactions can be calculated from the linear portions 
of the log vs/ dtime (196). The rate constants for these experiments 
are also presented in Table 16, from which it is seen that STX altered 
these constants.
A plot of STX concentration versus inhibition of rat muscle myosin 
ATPase activity (Fig. 42) indicates an optimal toxin level (25 pM) for 








Fig. U-0. Effects of STX on ATPase activity of rat muscle myosin, (a) control, (b) 100 pM STX. 












Fig. 41. Plot of log substrate concentration versus reaction time 
for rat muscle myosin ATPase activity in the presence (a) and in the 










Fig. 42. Effects of STX on ATPase activity of rat muscle myosin. 
184 jig protein. Conditions as in Table 16.
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All attempts to demonstrate an effect of either STX or TTX on 
brain myosin were unsuccessful, due primarily to the extremely low 
levels of specific activity present in such preparations. There may 
be more than five possible explanations for the low activities of 
brain myosin preparations! (i) a protein comparable to muscle myosin 
was not present in the neuronal tissues; (ii) the protein was present 
as actomyosin but could not be dissociated from actin by conventional 
methods employed for extracting myosin from muscle; (iii) the protein 
could be dissociated from actomyosin, however, it bound ATP irreversibly, 
and thus was inactivated; (iv) the protein was inactive due to the 
concomitant presence of an inhibitor or the absence of a specific 
activating substance; (v) the protein was very unstable under the 
conditions used for its isolation. Of these five possible explanations, 
evidence for at least two has been found. Namely, the activity of the 
enzyme decreased rapidly on storage and during the separation procedures. 
In addition, as previously noted, following attempts to dissociate 
brain actomyosin with ATP, the 280/260 mp absorbance ratio of myosin 
decreased and could not be significantly altered by either exhaustive 
dialysis, gel filtration, ion exchange chromatography, or by treatment 
with pancreatic ribonuclease. This could be related to the finding that 
brain microtubular protein binds nucleotides, particularly OTP, quite 
firmly (126). The facts that actomyosin-like proteins can be prepared 
from neuronal tissues, that an actin-like protein is also present in 
brain tissue (110, 126), and that a protein chromatographically like 
myosin, although of low enzymatic activity, can be isolated from brains, 
all suggest that the protein does exist in neuronal tissues. The
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failure to demonstrate its ATPase activity would then he due to any 
one or more of the remaining four possibilities cited above. This 
author prefers to entertain the possibility that a specific activating 
substance is required for expression of full brain myosin ATPase 
activity. A phospholipid requirement for muscle myosin ATPase activity 
has already been noted in the literature (197). If brain myosin is 
a component of nerve membranes, then it might be reasonable to anti­
cipate that it exists as a protein-phospholipid complex. Presumably 
the conformation of the protein in such a complex would be considerably 
influenced by the phospholipid. Addition of phospholipids to brain 
myosin preparations might enhance the enzymatic activity of this 
protein.
The preceding experiments have demonstrated that STX, TTX, and 
procaine do inhibit the activities of muscle actomyosin and muscle 
myosin. These agents also inhibit the activities of neuronal actomyosin- 
like proteins. This evidence supports the contention that electrically 
excitable cell membranes may contain contractile proteins; that these 
proteins could play a vital role in the excitation process, and that 
the biochemical mechanism of neuromuscular conduction block by STX and 
'TTX is mediated by the action of these toxins on the activities of the 
contractile proteins.
5. Effects of Saxitoxin and Tetrodotoxin on the 
Acetylcholine-Acetylcholinesterase System
It is well-known and widely accepted that acetylcholine (ACh) 
acts as a chemical transmitter in conducting electrical impulses across 
neuromuscular synapses of vertebrates and possibly many invertebrates
10?
as well (198, 199). The transmitter is normally inactivated very 
shortly after reaching the muscle end-plate by acetylcholinesterase 
(ACh-E), thus preventing uncontrolled, continuous muscle stimulation. 
Blockage of either ACh release or inhibition of its binding with the 
ACh-receptor produces paralysis by preventing neuromuscular synaptic 
conduction.
Several drugs and toxins are known to specifically interfere 
with various portions of the ACh - ACh-E system. Botulinum toxin 
inhibits ACh release (200), curare competes with ACh for its receptor 
(201), and ciguateratoxin exhibits anticholinesterase activity (201-203), 
in addition to competing with ACh for its receptor (204).
In addition to its role in synaptic conduction, the ACh - ACh-E 
system is believed by Nachnansohn (205-207) to be intrinsically involved 
in the generation and conduction of axonal impulses. As with Tasaki's 
theory (1J1), Nachnansohn also invokes membrane subunit conformational 
changes as the molecular basis for excitation, with ACh as the effector 
substance and ACh-E, or ACh-receptor, as the membrane protein undergoing 
conformational transition. If Nachnansohn is correct, it might be 
expected that any compound known to affect neural conduction would 
influence the ACh - ACh-E system.
The physiological effects of STX were described as being curare- 
form by Kellaway (208, 209), although Hutner and McLaughlin (10) later 
discounted Kellaway's interpretation and ascribed the STX effect to 
inhibition of ACh release. Bolton et al. (54), on the basis of 
physiological evidence, suggested that ACh-E inhibition could not 
explain the neuromuscular blocking actions of STX. Dettbarn et al.
108
(55i 36) independently reached the same conclusions. It seems, 
therefore, that the neuromuscular blocking activity of STX can be 
explained as inhibition of neuronal conduction prior to ACh release.
Similar findings for TTX have been reported. Fleisher et al. 
(100) concluded that TTX inhibited ACh release. Cheymol at al. (101) 
reached similar conclusions, noting that TTX acts much like cocaine. 
Dettbarn et al. (56) interpreted their studies as being indicative of 
a lack of anticholinesterase activity by TTX. In contrast, Yudkin (98) 
felt that the cardioinhibitory effects of TTX were referable to ACh-E 
inhibition, although he was not able to demonstrate this in vitro. 
Matsumaru and Yamamoto (99) suggested that high levels of TTX affected 
muscle end-plates. Kuriaki and Nagano (8 1), on the other hand, 
demonstrated an anticholinesterase effect of TTX, in vitro. They 
also found that TTX inhibited choline acetylase, which could explain 
the paralytic effects of TTX on the basis of transmitter synthesis 
inhibition.
Recent pharmacological studies (210) strongly imply that TTX 
intoxication can be relieved by administration of drug mixtures known 
to interact with the ACh- ACh-E system»
Evans (211, 212) has demonstrated that vertebrate, doraal 
(sensory) nerve fibers are 50 - 40 $ more sensitive to TTX and STX 
than are ventral (motor) fibers. Pertinent to this above observation 
is the finding by Brzin and Dettbarn (215) that the ACh-E activities 
of dorsal spinal roots are considerably less (1/16) than those of 
ventral roots, both of which are much lower than the activites of 
ACh-E recorded at muscle end-plate regions.
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It seemed possible, therefore, that, although the toxins may 
not appear to inhibit the neuromuscular synaptic ACh - ACh-E system, 
they might still produce axonal conduction block by inhibiting the 
axonal ACh - ACh-E system. Evans' findings of differential nerve 
sensitivity to the toxins might be related to the differential ACh-E 
activities of those fibers. Accordingly, if the ACh - ACh-E system is 
sensitive to SIX and TTX, then conduction block would be anticipated 
to progress in the orderi sensory nerve fibers, motor nerve fibers, 
and finally, neuromuscular synapses.
The effects of SIX and H X  on horse serum acetylcholinesterase 
(type IV, Sigma) activity are presented in Table 17. It is interesting 
to note that maximum anticholinesterase activities were observed with 
intermediate concentrations of both STX (5.55 pM) and TTX (O.785 pM); 
higher or lower toxin levels were less inhibitory. A 45.2 % ACh-E 
inhibition was achieved with STX and a JO.O % inhibition with TTX.
While the toxins inhibit horse serum cholinesterase activity, 
caution is advised in extrapolating these findings to possible effects 




Effects of STX and TTX on the ACh 








MgCl0 Cone. Inhibition 
(mM)2 {%)
1.55 140.0 5.75 4.0 19.4
1.55 11 11 a 27.6
6 .65 11 11 a 24.2
15.50 11 11 a -27.6
0 .10 280.0 a 40.0 9.8
1.55 • a a 7.8
2 .67 ■ a a 59.5
5.55 11 a a 45.2
15.5 11 a a 27.5
0 .10 11 7.50 a 0 .0
6 .65 H a a 15.2
15.50 M a a 18.4
26.50 ■ a a 17.1
TIX Cone. 
(pM)
O .0785 140.0 5.75 4.0 10.5
0.595 280.0 a 4o.o 18.0
0.785 a a a 50.0
O.0785 a 7.50 a 12.5
0.595 a a a 27.5
0.785 a a a 22.5
0.785 a a a 15.8
5.95 a a 15.8
7.85 a H a 7.5
* 1 .0 unit will hydrolyze 10.1 pg ACh./min., pH 7.4, 57°C.
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6. Effects of Saxitoxin on Shellfish Physiology 
The enigmatic resistance of shellfish to the toxic effects of
STX has long intrigued investigators. It is not uncommon to recover 
9 mg or more of STX from a single mussel after it has been feeding in
a G. catenella bloom (l6). 9.0 mg of STX is capable of killing
50,000 mice or several human adults!
Thesen (21^ ) noted that mussels would take up toxin present in 
their surrounding water. In contrast, Sommer et al. (20) found that 
mussels placed in water containing toxic mussel extract refused to 
filter-feed until the toxic water was removed, which may indicate that 
mussels are sensitive to dissolved STX (i.e., as contained within 
dinoflagellates). Sommer et al. (20) further demonstrated that the 
respiratory quotient of toxic mussels did not differ from that of 
non-toxic mussels.
There are three possible explanations for shellfish immunity 
to STX: (i) the shellfish could store the toxin in compartments,
thus precluding exposure of its neuromuscular system to the toxin;
(ii) the membranes of the shellfishes’ electrically excitable cells 
are chemically altered, such that its mechanism of excitation is directly 
resistant to the actions of STX (a similar explanation has been 
proffered for the resistance of puffer fish and Taricha nerves to TTX); 
or (iii), as Kao querried (3), perhaps the shellfish neuromuscular 
system is dependent upon a calcium, or, at least, a non-sodium mechanism 
for generating action potentials and would, therefore, be like the 
barnacle.
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In order to test these possibilities, the effects of SIX on 
the clam heart, the mussel anterior byssus retractor muscle (ABHM), 
and the mussel pedal ganglion were studied.
Technical difficulties limited the pedal ganglion study to a 
single preparation, the endogenous electrical activity of which was 
unaltered when bathed in a solution containing 50 yg SIX per ml.
Topical application of SIX (5° pg/ml) to electrically 
stimulated MytHu b  ABHM's was ineffectual in blocking contraction of 
these muscles. Application of crude Gymnodinium breve toxin, however, 
promptly blocked ABHM contractions, as previously reported by 
Sasner (215). On the basis of these studies, it appears that the 
ABHM's of Mytilus edulis are resistant to topically applied SIX.
This could be referable to the knowledge that the ABHM resembles 
vertebrate smooth muscles, which also are not affected by SIX (5).
Bathing of clam (Mya arenaria) hearts in sea water containing
0 .5 pg/ral STX consistently resulted in heart block within 5 -15 
minutes of exposure to toxin. Hearts were blocked during the systolic 
phase of the contraction (Fig. and remained blocked until the 
toxin was washed out with sea water. Complete recovery ensued in 
all cases.
Bullock and Horridge (199) suggest that ACh may be a normal 
transmitter substance mediating inhibition of certain pelecypod 
hearts. In view of the finding that S‘JX has anticholinesterase 
activity, it would seem likely that the mechanism involved in STX 
block of clam hearts could be the interaction of the toxin with heart 
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Fig. 3^. Effects of STX (l.5}iM) on contraction of Mya arenarla 
heart. Sea water bath, in situ heart, 23 C.
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clam hearts in diastole, not in systole. Eserine (physostigraine), 
a known ACh-E inhibitor, produces contraction block of Venus hearts 
in diastole, as expected (216). On the basis of this data, therefore, 
the action of STX on the clam heart should not be ascribed to ACh-E 
inhibition.
The observation that Mytilus hearts are relatively insensitive 
to ACh (217) poses the question of whether, or not, they are also 
insensitive to STX.
Clearly, much remains to be learned concerning the effects of 
SIX on shellfish physiology. These studies have demonstrated, 
nonetheless, that Mytilus ABHM's and perhaps mussel pedal ganglia are 
insensitive to relatively large amounts of STX. Hearts of Mya 
arenaria, on the other hand, are readily blocked by low concentrations 
of STX. It would appear that the mussel and the clam may have developed 
different mechanisms for surviving the lethal effects of STX; one has 
toxin-insensitive neuromuscular systems, while the other, one may 
speculate, must have devised toxin-compartmentalization mechanisms to 
preclude exposure of its sensitive heart to STX. A study of the effects 
of TTX on shellfish physiology would be of interest in light of the 
known differential effects of the two toxins on nerve systems of the 




It may be concluded, thati
1. Saxitoxin can be distinguished from similar, guanidine- 
containing compounds by means of thin-layer chromatography and thin- 
layer electrophoresis.
2. Chironomus thummi larvae may be paralyzed by immersion in 
STX solutions} however, all animals soon recover completely.
5. STX (90 pM), TEC (90 pM), and BU 58-271 (120 pM) enhance 
the swelling of isolated rat liver mitochondria incubated in buffered 
0 .1 M KC1 by 50 - 55 much the way arginine-rich histones affect 
mitochondrial swelling.
A. Swelling of isolated rat liver mitochondria suspended in 
buffered O.25 M sucrose is retarded 20 - 60 % by STX (0 .5 - 90.0 pM).
5. TTX (60 pM) markedly inhibits the effects of calcium on 
the light scattering properties of rat brain mitochondria incubated 
in buffered 0.4 M sucrose. The meaningfulness of this finding is in 
question, however, since calcium, rather than stimulating swelling, 
appeared to cause the mitochondria to contract.
6 . The activities of rat liver mitochondrial ATPases (latent 
and Mg44-independent) are stimulated 15 # by TTX (0.314 pM) and 5° ■
75 % SIX (0.332 - 0.01 pM). These findings are believed to indicate 
a degradative effect of the toxins on mitochondrial structure, consistent 
with reports of STX-induced kidney tubule mitochondria pathology.
7. The effects of the toxins on mitochondria are consistent 
with the known hypoglycemic effects of 'TTX and of other guanidine-
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containing compounds. Stimulation of mitochondrial ATPases activities 
would deplete cellular energy (ATP) stores derived by oxidative phos­
phorylation. This might invoke compensatory energy production activi­
ties, namely, glycolysis. Increased glucose utilization would result 
in hypoglycemia.
8. The effects of the toxins on mitochondria do not provide an 
explanation for the neuromuscular blocking properties of the toxins and 
are independent of conduction block.
9. TTX (8 - JO pM) has little effect on rat brain microsomal 
ATPases and does not influence the inhibition of (Na+-K+)-activated 
ATPase by ouabain. STX (1.0 pM), however, inhibits rat brain microsomal 
Mg*+-activated ATPase activity by 27 %. Ouabain inhibition of the 
(Na+-K*)-activated ATPase is not altered by the presence of STX
(0.1 - 50.0 jjM).
10. STX (1.0 pM) non-competitively inhibits the activity of 
rat brain microsomal (Mg^-Ca^J-activated ATPase, depressing the
T»az "  *■
11. A protein resembling muscle actomyosin can be isolated from 
crayfish ventral nerve cords and brains from rat, rabbit, sheep, and 
bovine sources. This protein has solubility, chromatographic, ATPase, 
superprecipitation, and ATP-induced dissociation characteristics that
are similar to those found for muscle actomyosin. Like muscle actomyosin, 
neuronal actomyosin ATPase activity is inhibited by PCMB and stimulated 
by AET. Furthermore, the ATPase activities of these proteins exhibit 
two pH optima (pH 6 .5 and 8.0), as does muscle actomyosin. The divalent 
cation requirements for ATPase activity of the neuronal proteins are
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also like those of muscle actomyosin. The enzymatic activities of 
neuronal and muscle actomyosins exhibit similar substrate inhibition 
responses at high ATP levels.
12. A protein resembling muscle myosin can also be isolated 
from brain tissue. This protein contains considerable 260 mp absorbing 
material -which cannot be eliminated by either BNase treatment, exhaustive 
dialysis, or by gel filtration. The presence of 260 mp absorbing material 
in neuronal myosin preparations appears to be associated with reduced 
ATPase activity of this protein and it is possible that covalently bound 
adenosine nucleotides are responsible for both the 260 mp absorbance as 
well as the reduced ATPase activity.
1J. It is suggested that neuronal contractile proteins, similar 
to muscle actomyosin, may be present in nerve cell membranes and function, 
in combination with phospholipids, as subunits capable of undergoing
conformational transitions concurrent with generation and conduction of
action potentials. The physicochemical hypothesis of molecular events 
occurring coincident with excitation, as presented by Tasaki (1J1), is 
invoked to explain the necessity of contractile proteins in electrically 
excitable cell membranes.
14. Crayfish ventral nerve cord actomyosin superprecipitation is 
inhibited 20 % by 27 pM SIX. The ATPase activity of this enzyme is 
inhibited 47 % by 5.5 pM STX.
15. STX (1.0 pM) inhibits the ATPase activity of rat brain acto­
myosin, reducing the 15 while leaving the unaltered. STX 
inhibition of rat brain actomyosin ATPase activity is characterized by
a reaction lag phase which is sometimes followed by an overshoot. Toxin
inhibition was greatest at optimal or higher substrate levels.
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16. Procaine (57 mM), which pharmacologically resembles the 
toxins, inhibits rat brain actomyosin ATPase activity 55 ~ 54 %•
The inhibition is greatest at lowest substrate concentrations.
17. TTX (60 pM) inhibits the ATPase activity of rat brain 
actomyosin in much the same way as does STX. A lag phase and inverse 
relationship with substrate concentration were also noted for TTX 
inhibition.
18. Eat brain actomyosin ATPase activity is stimulated by 
d-amphetamine (1.0 mM), a CNS stimulant, during the initial phase of 
the reaction. Amphetamine is inhibitory at higher substrate concen­
trations and at later times during the course of the reaction.
19. Bat brain actomyosin superprecipitation is inhibited 5® % 
by TTX (60 pM) in the presence of elevated substrate levels.
20. Rat brain actomyosin superprecipitation is inhibited 5° % 
by procaine (57 mM).
21. Hat muscle myosin ATPase activity is inhibited by STX.
The inhibition is maximal at 25 pM STX and is dependent upon calcium 
levels; inhibition being greater at lower concentrations of calcium.
The toxin produced a lag in the reactions as well as altering the 
reaction rates.
22. Horse serum ACh-E activity is inhibited 45 % by STX (5.5 pM) 
and 50 % by TTX (O.785 pM). Higher or lower concentrations of either 
toxin were less inhibitory.
25. STX (50 pg/ml) had no effect on the endogenous electrical 
activity of one pedal ganglion of Mytilus edulis that was studied, nor 
did the same concentration of STX have any effects on electrically 
stimulated contractions of Mytilus ABRM's.
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24. Contraction of Mya arenaria hearts were completely, hut 
reversibly, blocked in systole by 0.5 pg/ml STX, within 5 - 15 minutes 
of exposure to topical application of the toxin.
The results of this research indicate that the hypoglycemic 
effects of TTX may be attributed to a degradative action of the toxin 
on mitochondria. STX, too, had similar effects on mitochondria. These 
effects are independent of the neurotropic actions of the toxins.
Neuromuscular conduction block may be produced by the action of 
STX and TTX on axonal ACh - ACh-E systems. This suggestion is based on 
the finding that the toxins inhibit horse serum ACh-E activity. Differ­
ential sensitivities of motor axons, sensory fibers, and neuromuscular 
synapses to STX and TTX appear to be correlated with their relative 
ACh-E activities.
‘The contractile proteins examined during this project might be 
present in nerve and muscle cell membranes where they could play a vital 
role in the excitation process. Conformational changes of membrane con­
tractile protein could form the basis for changes in ionic conductances 
that occur during excitation. The inhibitory actions of SIX and TTX on 
the activities of neuronal contractile proteins may be the biochemical 
mechanism involved in the action of these toxins on neuromuscular 
conduction.
Shellfish that are known to feed with impunity on blooms of toxic 
dinoflagellates may owe their toxin-resistance to either of two mechanisms. 
The mussel, Mytilus edulis, appears, on the basis of preliminary findings, 
to possess a STX-insensitive neuromuscular system. The clam, Mya arenaria. 
on the other hand, may' have developed a means of compartmentalizing the 
toxin in order to prevent its heart, which is readily blocked by STX, 
from being exposed to the toxin.
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CHROMATOGRAPHY AND ELECTROPHORESIS OF SAXITOXIN AND 
RELATED GUANIDINE COMPOUNDS
Compound Rf Values for Solvent Systems (see Methods & Materials)
A B C D E F G H I J
Saxitoxin .25 .63 .43 .72 .7 6 .87 .68 .73 .81 .70
Agnatine .00 .06 .05 .26 .45 .57 .31 .09 .28 .03
Aminoguanidine .00 .49 .04 .61 .77 .65 .58 .55 .70 .56
Aminopterin - .33 - .61 .71 .80 .54 .40 .00 .37
Arcaine .06 .22 .02 .67 .54 .61 .58 .15 .5* .37
Arginine .04 .28 .00 .27 .44 .44 .59 .20 .30 .22
Creatin .22 .31 .03 .58 .74 .78 .64 .43 .58
Dicyandiamide .44 .75 .50 .78 .82 .69 .70 .81 .64 .68
Galegine .33 .66 .30 .74 .79 .87 .84 .73 .85 .79
Guanidine .17 .54 .19 .66 .72 .51 .60 .62 .54 .50
Guanine - - - - .43 - .48 - - -
Guany1-Urea-Fhosphat e .14 .55 .19 .68 .71 .55 .60 .85 - -
Methy1-Guanidine .28 .58 .21 .77 .73 .73 .67 .66 .63 .58
Streptomycin .00 .05 .00 .21 .24 .11 .38 .06 .24 .09
Sulfaguanidine .05 - - - .82 .82 .66 .06 .68 .62




Table A2. Thin-layer electrophoretic separations of 
__________saxitoxin and related compounds.____________











Saxitoxin 10.1 6.0 7.9 10.1 5.7
Agmatine 12.6 8.7 8.5 12.5 9.0
Aminoguanidine 15.7 10.2 8.8 10.6 -
Aminopterin - 0.0 0.0 0.0 0.0
Arcaine 15.2 7.2 8.6 15.5 8.7
Arginine 8.2 6.6 6.7 10.4• 6.5
Creatin 5.6 4.8 5.7 8.5 5.2
Creat in-Pho spbat e 5.6 5.1 5.7 8.5 4.9
Dicyandiamide 5.2 4.0 4.8 2.8 2.4
Galegine 9.6 7.0 7.5 9.5 6.5
Guanidine 14.5 11.2 9.8 14.5 8.8
Methy1-Guanidine 12.9 9.7 8.9 12.6 7.0
Streptomycin 10.0 6.8 7.4 11.5 7.5
Sulfaguanidine 5.5 4.4 5.0 — 5.6
